Chronic viral hepatitis

HEPATITIS_CHRONIC_VIRAL

hepatitis A virus infection: Acute inflammation of the liver caused by the hepatitis A virus. It is highly contagious and usually contracted through close contact with an infected individual or their feces, contaminated food or water.

Suggest a new description

Endpoint definition

↥

Endpoint definition steps	FinnGen
Phenotype data	520210
1. Apply sex-specific rule None	520210
2. Check conditions None	520210
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — B18 Cause of death: ICD-10 — B18 2 out of 7 registries used, show all original rules.	2176
4. Check minimum number of events None	2176
5. Include endpoints None	2176
6. Filter based on genotype QC (FinnGen only)	2176

Control definitions (FinnGen only)

Control exclude: IBD_VIRAL_HEPATITIS

Extra metadata

First used in FinnGen datafreeze: DF2
Parent code in ICD-10: B15-B19
Name in latin: Hepatitis viralis chronica

NAME	HEPATITIS_CHRONIC_VIRAL
CONTROL_EXCLUDE	IBD_VIRAL_HEPATITIS
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	B18
HD_ICD_9	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
HD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	B18
COD_ICD_9	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
COD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Chronic viral hepatitis based on the number of shared cases.

Similar with more cases:

Similar with less cases:

None

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	2176	925	1251
Unadjusted period prevalence (%)	0.45	0.32	0.55
Median age at first event (years)	35.71	33.56	37.31

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

Not a core endpoint, no data to show.

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
1993: Matched controls
19928

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

JJ1LE

NOMESCO Finland

Ultrasound elastography of liver

220.8

323.0

347

B18.2

ICD-10 Finland

Chronic viral hepatitis C

4503599627370496.0

323.0

1818

F19.29

ICD-10 Finland

Addiction caused by several drugs in combination and by other psychoactive substances UNS

151.4

323.0

400

WYA30

NOMESCO Finland

Preparations for expected poor cooperation

39.1

323.0

1214

763

N05AH04

ATC

quetiapine; oral

8.5

323.0

1015

2178

N05BA01

ATC

diazepam; systemic, rectal

12.0

323.0

850

1166

T36

ICD-10 Finland

Poisoning by systemic antibiotics

16.2

323.0

584

497

P19

ICPC

Drug abuse

72.6

323.0

460

F11.22

ICD-10 Finland

Addiction-induced dependence is currently independent but uses substitute intermittent medication

266.0

323.0

437

F15.2

ICD-10 Finland

Mental and behavioural disorders due to use of other stimulants, including caffeine, dependence syndrome

379.0

323.0

369

F19.1

ICD-10 Finland

Mental and behavioural disorders due to multiple drug use and use of other psychoactive substances, harmful use

83.1

319.5

356

F11.25

ICD-10 Finland

Relationship caused by opiates continuously used

188.2

309.4

317

F19.20

ICD-10 Finland

Addiction relationship caused by several drugs in combination and by other psychoactive substances currently independent

159.2

309.1

321

X69

ICD-10 Finland

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

17.5

299.7

495

368

Z72.2

ICD-10 Finland

Drug use

119.2

292.1

312

F10.1

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Harmful use

10.8

290.9

618

795

N05AH03

ATC

olanzapine; systemic

10.8

273.9

579

729

N05CD07

ATC

temazepam; oral

11.1

263.9

546

655

B18.1

ICD-10 Finland

Chronic viral hepatitis B without delta-agent

2510.5

247.0

234

F19.21

ICD-10 Finland

Addiction caused by several drugs in combination and by other psychoactive substances currently independent but staying in a controlling environment

171.0

245.2

254

F15.1

ICD-10 Finland

Mental and behavioural disorders due to use of other stimulants, including caffeine, harmful use

158.6

239.8

250

F11.24

ICD-10 Finland

Addiction-induced dependence caused by opiates active addiction

180.8

231.5

239

N05BA04

ATC

oxazepam; oral

5.4

230.9

902

2646

N03AE01

ATC

clonazepam; systemic

12.2

229.2

444

456

N07BB01

ATC

disulfiram; oral

11.2

223.9

456

516

N05AA02

ATC

levomepromazine; systemic

15.5

222.4

383

301

F11.29

ICD-10 Finland

Addiction caused by opiates UNS

184.5

222.1

229

N06AX11

ATC

mirtazapine; oral

4.7

219.3

1061

3856

F19.25

ICD-10 Finland

Addiction caused by several drugs in combination and by other psychoactive substances continuously used

152.0

218.6

229

F19.24

ICD-10 Finland

Addiction relationship caused by several drugs in combination and by other psychoactive substances active addiction

207.9

217.0

222

F29

ICD-10 Finland

Unspecified nonorganic psychosis

10.5

213.6

449

536

N05BA12

ATC

alprazolam; oral

7.9

209.8

537

891

112

Kela drug reimbursment

Severe psychotic and other severe mental disorders

7.6

203.5

532

907

B17.1

ICD-10 Finland

Acute hepatitis C

+∞

186.4

176

F10.29

ICD-10 Finland

Addiction caused by alcohol UNS

15.9

177.2

300

220

F13.22

ICD-10 Finland

Addiction relationship caused by sedatives and hypnotics currently independent but uses substitute intermittent medication

87.0

169.8

189

F13.25

ICD-10 Finland

Addiction caused by sedative and hypnotic continuous use

62.7

161.3

188

SPAT1275

SPAT

Drug rehabilitation and replacement therapy of opioid-dependent person

49.0

160.2

195

JN1AE

NOMESCO Finland

Ultrasound examination of upper part of abdomen

7.0

158.7

434

763

F60.30

ICD-10 Finland

Emotionally unstable personality disorder, impulsive

17.5

157.1

255

166

N06AB04

ATC

citalopram; systemic

4.3

156.6

734

2383

N05CF01

ATC

zopiclone; oral

4.0

155.5

830

3029

F11.20

ICD-10 Finland

Addiction-induced dependence caused by opiates currently independent

137.3

154.8

164

N05AX08

ATC

risperidone; systemic

7.2

152.8

405

678

EBA00

NOMESCO Finland

Extraction of tooth

3.6

152.3

1030

4560

F15.5

ICD-10 Finland

Mental and behavioural disorders due to use of other stimulants, including caffeine, psychotic disorder

272.0

149.5

151

A46

ICD-10 Finland

Erysipelas

5.6

146.4

485

1082

C07AA05

ATC

propranolol; systemic

4.2

146.2

688

2215

F10.20

ICD-10 Finland

Alcohol dependence currently independent

15.1

143.6

247

185

P18

ICPC

Medication abuse

43.3

142.7

178

F32.9

ICD-10 Finland

Depressive episode, unspecified

4.7

142.7

581

1619

L02.4

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle of limb

11.2

140.0

278

284

N05BA02

ATC

chlordiazepoxide; systemic

18.7

136.3

215

128

F60.2

ICD-10 Finland

Dissocial personality disorder

78.6

135.7

153

SPAT1272

SPAT

Drug screening

69.9

135.2

155

P15

ICPC

Chronic alcohol abuse

9.6

130.2

282

337

F41.9

ICD-10 Finland

Anxiety disorder, unspecified

5.0

128.7

477

1189

F10.25

ICD-10 Finland

Alcohol dependence continuous use

15.3

123.3

210

152

F13.29

ICD-10 Finland

Addiction caused by sedative and hypnotic UNS

66.3

122.9

142

N05AF03

ATC

chlorprothixene; systemic

11.4

121.1

237

233

F19.30

ICD-10 Finland

Withdrawal symptoms caused by several drugs in combination and by other psychoactive substances uncomplicated

618.8

119.4

117

F11.21

ICD-10 Finland

Addiction-indiced dependence caused by opiates currently independent but staying in controlling environment

257.4

119.3

121

F19.2

ICD-10 Finland

Mental and behavioural disorders due to multiple drug use and use of other psychoactive substances, dependence syndrome

216.4

119.0

122

F10.21

ICD-10 Finland

Alcohol dependence currently abstinent, but staying in restrictive environment

21.7

118.5

177

N06AB06

ATC

sertraline; oral

4.6

118.2

468

1238

F19.9

ICD-10 Finland

Mental and behavioural disorders due to multiple drug use and use of other psychoactive substances, unspecified mental and behavioural disorder

86.2

115.7

129

SPAT1265

SPAT

Breathalyser

20.4

115.5

176

F13.20

ICD-10 Finland

Addiction relationship caused by sedatives and hypnotics currently independent

67.7

115.5

133

K04.5

ICD-10 Finland

Chronic apical periodontitis

3.4

113.4

731

2935

SPAT1309

SPAT

Guidance related to psychoactive substances / risk behaviour

9.7

111.7

239

277

F12.1

ICD-10 Finland

Mental and behavioural disorders due to use of cannabinoids, harmful use

38.8

110.6

141

N03AG01

ATC

valproic acid; systemic, rectal

6.0

110.2

335

654

O98.4

ICD-10 Finland

Viral hepatitis complicating pregnancy, childbirth and the puerperium

1117.4

109.5

106

F10.24

ICD-10 Finland

Alcohol depence active use

15.8

109.0

183

127

F20.00

ICD-10 Finland

Paranoid schizophrenia continuous

10.7

106.8

215

222

N06AX16

ATC

venlafaxine; oral

3.9

106.1

525

1691

F20.9

ICD-10 Finland

Schizophrenia, unspecified

11.3

106.0

208

204

T74.1

ICD-10 Finland

Physical abuse

10.4

105.3

216

231

N06AB03

ATC

fluoxetine; oral

4.5

104.9

428

1153

N05AD01

ATC

haloperidol; systemic

12.2

104.8

197

177

F13.24

ICD-10 Finland

Addiction relationship caused by sedative and hypnotic active addiction

64.3

104.3

121

AA1AD

NOMESCO Finland

CT of head and brain

3.7

104.2

550

1867

WX110

NOMESCO Finland

Local anesthesy

3.2

103.2

1628

11542

N05AH02

ATC

clozapine; systemic

10.4

103.2

211

224

D72

ICPC

Viral hepatitis

221.5

102.5

105

Z86.4

ICD-10 Finland

Personal history of psychoactive substance abuse

53.5

101.2

121

K74.6

ICD-10 Finland

Other and unspecified cirrhosis of liver

45.4

100.6

124

R56.8

ICD-10 Finland

Other and unspecified convulsions

6.5

99.2

278

485

F11.30

ICD-10 Finland

Withdrawal symptoms caused by opiates uncomplicated

138.4

99.0

105

X44

ICD-10 Finland

Accidental poisoning by and exposure to other and unspecified drugs, medicaments and biological substances

14.4

98.7

172

130

F11.1

ICD-10 Finland

Mental and behavioural disorders due to use of opioids, harmful use

109.6

95.9

104

XF400

NOMESCO Finland

ECG with 12 standard connections

4.1

95.6

424

1226

-1

NOMESCO Finland

2.7

94.9

944

4914

WYA05

NOMESCO Finland

Emergency visit or other similar visit involving procedures

2.7

93.9

1222

7429

N06AA12

ATC

doxepin; systemic

8.4

93.4

216

283

EBA30

NOMESCO Finland

Excision of root of tooth

7.0

93.2

246

394

N03AX16

ATC

pregabalin; oral

3.3

93.1

592

2289

3049X

ICD-9 Finland

Drug dependence, Unspecified drug dependence

169.8

93.0

N05BE01

ATC

buspirone; oral

9.4

92.7

200

233

GD1UA

NOMESCO Finland

Thorax X-ray examination outside radiological department

4.2

92.3

404

1150

F13.1

ICD-10 Finland

Mental and behavioural disorders due to use of sedatives or hypnotics, harmful use

43.1

91.6

114

GD1AA

NOMESCO Finland

Thorax X-ray examination

2.8

91.4

863

4321

F10.09

ICD-10 Finland

Alcohol intoxication UNS

9.7

91.2

193

217

Z00.4

ICD-10 Finland

General psychiatric examination, not elsewhere classified

4.0

89.7

411

1217

N05AX12

ATC

aripiprazole; systemic

5.8

89.5

273

528

F10.00

ICD-10 Finland

Alcohol-related acute intoxication uncomplicated

11.4

88.6

172

164

EBA05

NOMESCO Finland

Complicated extraction of tooth

3.1

87.9

605

2459

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

2.6

86.2

1008

5656

A49.9

ICD-10 Finland

Bacterial infection, unspecified

5.1

85.4

292

644

JX1XE

NOMESCO Finland

Other ultrasound examinaton of alimentary organs

134.5

84.7

K02.1

ICD-10 Finland

Caries of dentine

2.6

84.2

1428

9777

N06AB10

ATC

escitalopram; oral

2.9

84.1

648

2824

F60.9

ICD-10 Finland

Personality disorder, unspecified

12.1

83.5

157

140

N05CF02

ATC

zolpidem; oral

3.3

82.7

511

1910

F10.26

ICD-10 Finland

Alcohol dependence periodic alcoholism

12.0

82.2

155

139

GD1QA

NOMESCO Finland

Supine thorax X-ray examination

4.8

82.1

302

719

SPAT1254

SPAT

Administration of medicine

4.0

81.1

366

1061

Z22.5

ICD-10 Finland

Carrier of viral hepatitis

820.5

81.0

J18.9

ICD-10 Finland

Pneumonia, unspecified

3.3

79.7

477

1737

L03.1

ICD-10 Finland

Cellulitis of other parts of limb

10.0

79.3

165

179

F19.00

ICD-10 Finland

Intoxication caused by several drugs in combination or by other psychoactive substances uncomplicated

68.0

79.2

SPAT1227

SPAT

Substance abuse rehabilitation

20.3

78.4

119

F20.30

ICD-10 Finland

Undifferentiated schizophrenia continuous

9.8

76.8

161

177

A41.0

ICD-10 Finland

Sepsis due to Staphylococcus aureus

16.7

76.0

124

X59

ICD-10 Finland

Exposure to unspecified factor

2.9

75.1

567

2404

N06AB05

ATC

paroxetine; oral

4.7

74.4

276

659

F20.09

ICD-10 Finland

Paranoid schizophrenia UNS

15.7

74.2

124

P16

ICPC

Acute alcohol abuse

10.1

74.2

153

163

3039X

ICD-9 Finland

Alcohol dependence syndrome, Other and unspecified alcohol dependence

19.9

74.0

113

N05AB01

ATC

dixyrazine; systemic

22.1

73.9

109

K08.1

ICD-10 Finland

Loss of teeth due to accident, extraction or local periodontal disease

4.6

73.8

278

674

F61.0

ICD-10 Finland

Mixed personality disorders

9.6

73.5

156

175

N02AX02

ATC

tramadol; systemic, rectal

2.4

73.4

885

4902

SAA01

NOMESCO Finland

Simple examination of mouth

2.7

73.1

1609

12150

EB1AA

NOMESCO Finland

Tooth X-ray examination

2.4

73.0

1292

8683

WX290

NOMESCO Finland

Other blockade of nerve

2.4

73.0

1214

7911

F10.30

ICD-10 Finland

Withdrawal symptoms caused by alcohol uncomplicated

13.4

72.4

129

102

S01.0

ICD-10 Finland

Open wound of scalp

4.7

71.4

264

627

TPH04

NOMESCO Finland

Cathetrisation of vein

3.0

70.9

494

1979

WX700

NOMESCO Finland

Respiratory and circulatory monitoring

3.3

70.4

410

1446

N03AX12

ATC

gabapentin; oral

3.4

70.4

400

1386

F60.31

ICD-10 Finland

Emotionally unstable personality disorder, borderline condition

11.0

70.2

138

134

A06AD11

ATC

lactulose; oral

4.1

69.9

298

813

F19.59

ICD-10 Finland

Psychotic disorder caused by several drugs in combination and by other psychoactive substances UNS

241.6

68.7

TJJ00

NOMESCO Finland

Percutaneous needle biopsy of liver

147.1

67.4

Z53.2

ICD-10 Finland

Procedure not carried out because of patient's decision for other and unspecified reasons

12.7

67.2

123

103

EBA15

NOMESCO Finland

Extraction of large number of teeth

7.8

66.7

160

220

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

3.4

66.5

371

1264

T40.9

ICD-10 Finland

Poisoning: Other and unspecified psychodysleptics [hallucinogens]

106.6

66.3

R4110

NOMESCO Finland

Physiotherapy

2.6

65.2

588

2741

S06.0

ICD-10 Finland

Concussion

3.5

65.1

338

1087

JJ2AT

NOMESCO Finland

Biopsy of liver with ultrasound guidance

10.2

65.1

133

139

N05AA01

ATC

chlorpromazine; systemic, rectal

14.0

64.7

113

N05AB03

ATC

perphenazine; systemic, rectal

6.3

64.1

179

305

F10.39

ICD-10 Finland

Withdrawal symptoms caused by alcohol UNS

13.5

63.8

113

IEY05

NOMESCO Finland

Dedicated profession-specific psychiatric intervention, individual

6.6

63.7

172

280

F19.26

ICD-10 Finland

Addiction relationship caused by several drugs in combination and by other psychoactive substances periodic addiction

59.0

63.1

O35.5

ICD-10 Finland

Maternal care for (suspected) damage to fetus by drugs

136.4

62.2

F15.3

ICD-10 Finland

Mental and behavioural disorders due to use of other stimulants, including caffeine, withdrawal state

322.6

61.7

ICZ03

NOMESCO Finland

Participation in compiling a psychiatric treatment plan

6.7

61.3

163

260

F13.3

ICD-10 Finland

Mental and behavioural disorders due to use of sedatives or hypnotics, withdrawal state

61.3

60.9

F41.2

ICD-10 Finland

Mixed anxiety and depressive disorder

3.3

60.1

343

1181

WX892

NOMESCO Finland

Monitored bed care

4.6

59.4

223

534

N04AA02

ATC

biperiden; systemic

9.6

59.3

125

138

F13.21

ICD-10 Finland

Addiction relationship caused by sedatives and hypnotics currently independent but staying in a controlling environment

96.0

59.2

J01FF01

ATC

clindamycin; systemic

2.4

58.6

641

3279

F11.2

ICD-10 Finland

Mental and behavioural disorders due to use of opioids, dependence syndrome

157.2

58.2

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

2.5

58.1

545

2568

F60.3

ICD-10 Finland

Emotionally unstable personality disorder

12.4

57.5

106

F31.9

ICD-10 Finland

Bipolar affective disorder, unspecified

6.3

57.3

160

272

F19.09

ICD-10 Finland

Intoxication caused by several drugs in combination and by other psychoactive substances UNS

154.5

57.2

Z71.2

ICD-10 Finland

Person consulting for explanation of investigation findings

2.6

57.1

516

2378

IFC01

NOMESCO Finland

Withdrawal and replacement therapy for opioid addiction

198.9

56.3

F19.50

ICD-10 Finland

Psychotic disorder caused by several drugs in combination and by other psychoactive substances schizophrenic

91.4

56.2

F19.22

ICD-10 Finland

Addiction caused by several drugs in combination and by other psychoactive substances currently independent but using substitute intermittent medication

123.6

56.1

F32.2

ICD-10 Finland

Severe depressive episode without psychotic symptoms

3.8

56.0

263

773

K04.4

ICD-10 Finland

Acute apical periodontitis of pulpal origin

3.4

56.0

302

993

F20.39

ICD-10 Finland

Undifferentiated schizophrenia UNS

15.1

55.8

K08.3

ICD-10 Finland

Retained dental root

4.3

55.8

225

577

N05AD03

ATC

melperone; systemic

18.1

55.4

N03AX09

ATC

lamotrigine; oral

4.3

55.3

220

557

Z76.9

ICD-10 Finland

Person encountering health services in unspecified circumstances

4.0

55.1

240

660

Y07

ICD-10 Finland

Other maltreatment

13.3

55.1

P01

ICPC

Feeling anxious/nervous/tense

3.0

54.9

360

1359

IAA01

NOMESCO Finland

Assessment of need for psychiatric treatment

6.5

54.9

149

244

N05CD08

ATC

midazolam; nasal, systemic

12.5

54.6

100

WYA30

SPAT

28.4

54.2

T40.6

ICD-10 Finland

Poisoning: Other and unspecified narcotics

191.9

54.2

F12.29

ICD-10 Finland

Addiction caused by cannabis UNS

43.2

54.1

WZB00

NOMESCO Finland

Telephone receipt or other advice

2.2

54.0

728

4085

KMAK

NOMESCO Finland

2.1

53.9

1252

8885

A41.9

ICD-10 Finland

Sepsis, unspecified

8.3

53.8

123

156

K05.31

ICD-10 Finland

Periodontitis pronounced

3.7

53.3

251

738

P29

ICPC

Psychological sympt/compl other

3.8

53.2

244

702

K04.7

ICD-10 Finland

Periapical abscess without sinus

4.3

53.1

212

538

N05AF05

ATC

zuclopenthixol; systemic

14.2

52.6

N06BA04

ATC

methylphenidate; oral

6.0

52.6

152

270

0705A

ICD-9 Finland

Viral hepatitis, Other specified viral hepatitis without mention of hepatic coma

+∞

52.3

F90.0

ICD-10 Finland

Disturbance of activity and attention

5.2

52.2

171

353

K70.3

ICD-10 Finland

Alcoholic cirrhosis of liver

15.1

51.7

V03AA01

ATC

10.4

51.3

103

104

B18.9

ICD-10 Finland

Chronic viral hepatitis, unspecified

+∞

51.3

F10.9

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Unspecified mental and behavioural disorder

13.6

50.7

F33.9

ICD-10 Finland

Recurrent depressive disorder, unspecified

4.7

50.6

183

420

P72

ICPC

Schizophrenia

7.4

50.5

124

176

F10.2

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Dependence syndrome

15.7

50.1

3044A

ICD-9 Finland

Drug dependence, Amphetamine and other psychostimulant dependence

136.0

50.0

Z76.8

ICD-10 Finland

Persons encountering health services in other specified circumstances

5.4

49.9

158

313

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

3.9

49.6

220

613

L17

ICPC

Foot/toe symptom/complaint

2.5

49.6

477

2249

S18

ICPC

Laceration/cut

2.1

49.5

763

4504

R4160

NOMESCO Finland

Other therapy enhancing rehabilitation

7.8

49.2

117

158

Z71.8

ICD-10 Finland

Other specified counselling

2.3

49.2

582

3046

K02.9

ICD-10 Finland

Dental caries, unspecified

9.5

48.8

103

114

ICB01

NOMESCO Finland

Psychiatric treatment plan, standard

6.0

48.5

139

244

S10

ICPC

Boil/carbuncle

4.5

48.1

181

432

K04.0

ICD-10 Finland

Pulpitis

2.8

47.7

361

1483

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

2.1

47.5

762

4551

F15.0

ICD-10 Finland

Mental and behavioural disorders due to use of other stimulants, including caffeine, acute intoxication

62.8

47.5

TKC20

NOMESCO Finland

Catheterisation of bladder

4.5

47.4

178

424

Z46.3

ICD-10 Finland

Fitting and adjustment of dental prosthetic device

13.5

47.1

N05BA06

ATC

lorazepam; systemic, sublingual

4.9

46.8

163

359

K75.9

ICD-10 Finland

Inflammatory liver disease, unspecified

14.0

46.8

F51.0

ICD-10 Finland

Nonorganic insomnia

2.7

46.5

375

1597

3018X

ICD-9 Finland

Personality disorders, Other personality disorders[MUU TAI SEKAMUOTOINEN PERSOONALLISUUSHÄIRIÖ]

16.1

46.4

W01

ICD-10 Finland

Fall on same level from slipping, tripping and stumbling

2.3

46.4

564

2972

339

Kela drug reimbursment

Product containing buprenorfine and naloxone

240.5

46.2

F12.25

ICD-10 Finland

Dependence caused by cannabis continuous use

76.3

46.2

F10.31

ICD-10 Finland

Withdrawal symptoms caused by alcohol with seizures

15.8

46.1

A01

ICPC

Pain general/multiple sites

4.0

45.8

196

528

D10

ICPC

Vomiting

3.5

45.7

234

733

N06AX03

ATC

mianserin; oral

5.1

45.4

150

312

Z76.0

ICD-10 Finland

Issue of repeat prescription

2.6

45.2

383

1673

T51.0

ICD-10 Finland

Toxic effect: Ethanol

16.1

44.6

Z72.1

ICD-10 Finland

Alcohol use

9.6

44.6

101

R50.9

ICD-10 Finland

Fever, unspecified

2.7

44.6

343

1417

P74

ICPC

Anxiety disorder/anxiety state

4.7

44.5

161

369

IGV01

NOMESCO Finland

Psychiatric network contact

12.6

44.1

X78

ICD-10 Finland

Intentional self-harm by sharp object

15.0

44.0

SPE90

NOMESCO Finland

Other fitting and preparation of partial tooth prosthesis

10.0

43.6

N05AN01

ATC

lithium; oral

5.8

43.5

128

232

C03CA01

ATC

furosemide; systemic

2.7

43.5

326

1326

IBZ01

NOMESCO Finland

Profession-specific psychiatric evaluation

7.0

43.4

111

167

F19.53

ICD-10 Finland

Psychotic disorder caused by several drugs in combination and by other psychoactive substances polymorphic

436.8

43.4

M79.6

ICD-10 Finland

Pain in limb

2.1

43.0

681

4006

R74

ICPC

Upper respiratory infection acute

2.0

42.9

729

4410

Z35.7

ICD-10 Finland

Supervision of high-risk pregnancy due to social problems

35.3

42.7

X99.9

ICD-10 Finland

Assault by sharp object by unknown person

35.3

42.7

I85.9

ICD-10 Finland

Oesophageal varices without bleeding

20.0

42.4

E950A

ICD-9 Finland

Suicide and self-inflicted poisoning by solid or liquid substances

13.7

42.4

Z03.2

ICD-10 Finland

Observation for suspected mental and behavioural disorders

7.0

42.3

108

162

F20.0

ICD-10 Finland

Paranoid schizophrenia

14.4

41.6

A03

ICPC

Fever

2.3

41.0

450

2239

P99

ICPC

Psychological disorders other

5.0

41.0

139

297

Y04.9

ICD-10 Finland

Assault by bodily force by unknown person

9.2

40.9

F12.20

ICD-10 Finland

Dependence caused by cannabis currently independent

40.2

40.8

L03.9

ICD-10 Finland

Cellulitis, unspecified

7.8

40.7

128

A02BC02

ATC

pantoprazole; systemic

1.9

40.6

1144

8297

J20.9

ICD-10 Finland

Acute bronchitis, unspecified

2.5

40.5

378

1731

F19.40

ICD-10 Finland

Withdrawal symptoms with delirium caused by several drugs in combination and by other psychoactive substances without seizures

405.4

40.2

L02

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle

4.9

40.1

136

291

F11.39

ICD-10 Finland

Withdrawal symptoms caused by opiates without information about seizures

142.9

39.9

SPAT1247

SPAT

Outpatient detoxication and monitoring

15.5

39.9

TPH07

NOMESCO Finland

Cathetrisation of artery

3.4

39.8

208

660

R05

ICPC

Cough

2.3

39.6

453

2296

F32.10

ICD-10 Finland

Moderate depressive episode without somatic syndrome

2.8

39.2

278

1087

X57

ICD-10 Finland

Unspecified privation

6.3

39.2

108

180

T65.9

ICD-10 Finland

Toxic effect: Toxic effect of unspecified substance

28.6

39.1

L12

ICPC

Hand/finger symptom/complaint

2.6

38.9

322

1381

F12.21

ICD-10 Finland

Dependence caused by cannabis currently independent but staying in a controlling environment

41.0

38.5

3018D

ICD-9 Finland

Personality disorders, Other personality disorders[EPÄVAKAA PERSOONALLISUUS]

20.9

38.4

D11

ICPC

Diarrhoea

2.6

38.3

321

1385

SPAT1240

SPAT

Therapeutic discussion

2.6

38.2

324

1406

IGY01

NOMESCO Finland

Accelerated psychiatric treatment contact

5.9

38.2

111

198

S76

ICPC

Skin infection other

4.5

38.2

142

334

O04.9

ICD-10 Finland

Medical abortion, complete or unspecified, without complication

3.0

38.1

236

845

SFA30

NOMESCO Finland

Filling on tree or more surfaces of tooth

1.9

38.0

840

5542

F12.24

ICD-10 Finland

Addiction caused by cannabis active addiction

104.6

37.8

T40.2

ICD-10 Finland

Poisoning: Other opioids

136.0

37.8

RS220

NOMESCO Finland

8.2

37.7

109

IAB10

NOMESCO Finland

Psychiatric consultation concerning substance abuse

51.1

37.7

F99

ICD-10 Finland

Mental disorder, not otherwise specified

5.6

37.7

114

214

F10.40

ICD-10 Finland

Withdrawal symptoms and delirium caused by alcohol without seizures

11.5

37.6

N06AA06

ATC

trimipramine; systemic

6.5

37.3

100

161

NA1AD

NOMESCO Finland

Cervical spine CT examination

4.5

37.1

137

320

F39

ICD-10 Finland

Unspecified mood [affective] disorder

6.0

37.0

105

182

OAB43

SPAT

0.3

36.9

122

3165

J69.0

ICD-10 Finland

Pneumonitis due to food and vomit

11.7

36.9

F23.99

ICD-10 Finland

Acute and transient psychosis, unspecified UNS

17.5

36.8

QCB00

NOMESCO Finland

Suture of skin of upper limb

8.0

36.8

110

F20

ICD-10 Finland

Schizophrenia

11.3

36.8

K92.0

ICD-10 Finland

Haematemesis

7.2

36.7

131

N06AX12

ATC

bupropion; oral

3.0

36.6

236

866

A02BC01

ATC

omeprazole; systemic

2.1

36.5

475

2539

Z04.8

ICD-10 Finland

Examination and observation for other specified reasons

2.6

36.3

286

1187

N06AX21

ATC

duloxetine; oral

2.7

36.0

270

1090

WX002

NOMESCO Finland

Sedation and analgesia

2.4

36.0

353

1652

F11.9

ICD-10 Finland

Mental and behavioural disorders due to use of opioids, unspecified mental and behavioural disorder

81.7

35.9

L08.8

ICD-10 Finland

Other specified local infections of skin and subcutaneous tissue

5.8

35.9

105

189

N07BC51

ATC

buprenorphine, combinations; sublingual

188.3

35.9

F19.39

ICD-10 Finland

Withdrawal symptoms caused by several drugs in combination and by other psychoactive substances UNS

129.0

35.8

B23.1

ICD-10 Finland

HIV disease resulting in (persistent) generalized lymphadenopathy

14.3

35.7

J15.9

ICD-10 Finland

Bacterial pneumonia, unspecified

3.6

35.5

173

518

F11.26

ICD-10 Finland

Addiction caused by opiates intermittent drug addiction

+∞

35.5

B16.9

ICD-10 Finland

Acute hepatitis B without delta-agent and without hepatic coma

+∞

35.5

IFC99

NOMESCO Finland

Other biological psychiatric intervention

33.6

35.4

IGY02

NOMESCO Finland

Psychiatric monitoring contact

5.2

35.4

113

226

N03AF01

ATC

carbamazepine; oral, rectal

4.2

35.1

140

352

SFA10

NOMESCO Finland

Fillning on one surface of tooth

1.8

34.7

1133

8427

T50.9

ICD-10 Finland

Poisoning: Other and unspecified drugs, medicaments and biological substances

16.4

34.7

RS120

NOMESCO Finland

52.3

34.5

P01AB01

ATC

metronidazole; oral, rectal

1.9

34.5

739

4772

WX408

NOMESCO Finland

General anesthesy, balanced

2.0

34.2

526

3001

F13.2

ICD-10 Finland

Mental and behavioural disorders due to use of sedatives or hypnotics, dependence syndrome

30.6

33.9

TPH15

NOMESCO Finland

Insertion of central venous catheter through external or internal jugular vein

3.9

33.3

146

400

Y09

ICD-10 Finland

Assault by unspecified means

12.1

33.2

F05.9

ICD-10 Finland

Delirium, unspecified

8.7

33.0

T40.1

ICD-10 Finland

Poisoning: Heroin

332.4

33.0

3043A

ICD-9 Finland

Drug dependence, Cannabis dependence

118.7

32.8

F92.0

ICD-10 Finland

Depressive conduct disorder

21.3

32.7

SGA01

NOMESCO Finland

Tooth opening as first aid

2.1

32.7

445

2409

S62.3

ICD-10 Finland

Fracture of other metacarpal bone

4.3

32.6

125

303

RS310

NOMESCO Finland

49.6

32.6

SFA40

NOMESCO Finland

Replacement of krone of tooth

2.2

32.5

406

2116

WX730

NOMESCO Finland

Conventional respirator

8.1

32.5

B18.0

ICD-10 Finland

Chronic viral hepatitis B with delta-agent

+∞

32.4

N05CD02

ATC

nitrazepam; oral

11.4

32.3

R02

ICPC

Shortness of breath/dyspnoea

2.8

32.2

227

879

T40.4

ICD-10 Finland

Poisoning: Other synthetic narcotics

322.0

31.9

Z04.0

ICD-10 Finland

Blood-alcohol and blood-drug test

17.7

31.9

IEV99

NOMESCO Finland

Other psychiatric network intervention

15.1

31.9

SPAT1148

SPAT

Treatment of chronic ulcer or burn

2.8

31.8

221

848

J44.8

ICD-10 Finland

Other specified chronic obstructive pulmonary disease

3.9

31.8

137

370

F10.23

ICD-10 Finland

Alcohol dependence currently abstinent but using aversion-inducing or inhibitory medication

11.0

31.8

K02.2

ICD-10 Finland

Caries of cementum

4.5

31.7

117

273

SPAT1301

SPAT

No procedures

1.9

31.7

548

3257

L03

ICPC

Low back symptom/complaint

2.0

31.6

466

2604

K04.1

ICD-10 Finland

Necrosis of pulp

2.5

31.6

283

1257

Z03

ICD-10 Finland

Medical observation and evaluation for suspected diseases and conditions, ruled out

3.0

31.2

193

687

N02BE01

ATC

paracetamol; systemic, rectal

1.9

31.2

1583

13345

SFA20

NOMESCO Finland

Filling on two surfaces of tooth

1.8

31.2

1232

9573

F41.09

ICD-10 Finland

UNS Panic Syndrome

4.2

31.0

122

303

SPAT1260

SPAT

Consultation of another employee

2.3

30.9

325

1562

Z01.2

ICD-10 Finland

Dental examination

1.8

30.8

858

5982

A28

ICPC

Limited function/disability NOS

3.1

30.7

180

618

Z50.8

ICD-10 Finland

Care involving use of other rehabilitation procedures

3.2

30.3

170

565

F15.9

ICD-10 Finland

Mental and behavioural disorders due to use of other stimulants, including caffeine, unspecified mental and behavioural disorder

+∞

30.3

J01MA12

ATC

levofloxacin; systemic

2.3

30.1

318

1533

N10

ICD-10 Finland

Acute tubulo-interstitial nephritis

2.8

30.1

203

763

SGA02

NOMESCO Finland

Opening and dilatation of root canal of tooth

2.3

30.0

306

1450

Z01.6

ICD-10 Finland

Radiological examination, not elsewhere classified

2.7

30.0

218

860

F11.23

ICD-10 Finland

Addiction-induced dependence is currently independent but uses aversion-inducing medication

306.8

29.9

R11

ICD-10 Finland

Nausea and vomiting

3.0

29.7

184

655

R1210

NOMESCO Finland

Medical assessment of need and possibilities to rehabilitation

8.2

29.7

F22.0

ICD-10 Finland

Delusional disorder

7.8

29.6

IER04

NOMESCO Finland

Rehabilitative psychiatric group intervention, functional

9.5

29.5

QCB05

NOMESCO Finland

Revision of wound of skin of upper limb

9.8

29.5

K10.3

ICD-10 Finland

Alveolitis of jaws

3.5

29.4

146

443

J01DB01

ATC

cefalexin; oral

1.9

29.4

1621

13865

Z72.0

ICD-10 Finland

Tobacco use

5.2

29.3

189

SPAT1234

SPAT

Support of social functional capacity

4.2

29.2

114

281

Z01.7

ICD-10 Finland

Laboratory examination

2.5

29.1

244

1043

Z03.9

ICD-10 Finland

Observation for suspected disease or condition, unspecified

2.2

29.0

342

1731

F17.29

ICD-10 Finland

Addiction caused by tobacco UNS

6.3

28.8

128

X84

ICD-10 Finland

Intentional self-harm by unspecified means

19.9

28.7

N07BA03

ATC

varenicline; oral

3.0

28.6

175

618

SPAT1307

SPAT

Psychosocial counselling and guidance

2.8

28.6

193

727

JN4BD

NOMESCO Finland

Extensive body CT

2.9

28.5

186

685

R18

ICD-10 Finland

Ascites

9.5

28.5

B24

ICD-10 Finland

Unspecified human immunodeficiency virus [HIV] disease

19.1

28.3

K04.09

ICD-10 Finland

Pulpit UNS

3.3

28.3

151

485

B18.8

ICD-10 Finland

Other chronic viral hepatitis

+∞

28.2

Y19

ICD-10 Finland

Poisoning by and exposure to other and unspecified chemicals and noxious substances, undetermined intent

24.8

27.9

Z72.8

ICD-10 Finland

LabWAS

↥

(ID) Name

N Cases

N Controls

-log₁₀(p)

cases

controls

unit

cases

controls

-log₁₀(p)

N cases

N controls

(3000764) Benzodiazepines [Presence] in Urine

844

1454

8.85

307.65

12.6

1.7

—

(3029536) Hepatitis C virus RNA [Units/volume] (viral load) in Specimen by NAA with probe detection

822

235.29

307.65

2.1

1.3

iu/ml

1644551.2

—

137

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

1163

3294

6.44

307.65

3.4

1.8

1.7

1.4

25.12

1038

2982

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

1669

5941

8.77

307.65

5.8

3.3

u/l

51.0

31.3

29.69

1586

5669

(3017143) Hepatitis C virus Ab [Presence] in Serum

1052

2979

5.90

307.65

1.9

1.7

—

(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing

553

+∞

307.65

1.2

0.0

—

(3027944) Amphetamines [Presence] in Urine

822

1438

8.58

307.65

11.8

1.7

—

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

1807

7744

8.86

307.65

8.1

6.0

umol/l

11.7

11.2

0.68

1737

7375

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

901

106

144.36

307.65

2.1

1.2

—

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

708

1277

7.74

307.65

2.7

2.4

g/l

0.2

21.67

638

1205

(3028300) Cannabinoids [Presence] in Urine

845

1469

8.77

307.65

12.8

1.7

—

(3024561) Albumin [Mass/volume] in Serum or Plasma

1558

5979

6.65

307.65

5.8

5.2

g/l

36.2

37.0

5.44

1487

5635

(3033658) Prothrombin time (PT) actual/Normal

1224

3882

5.92

307.65

6.4

3.9

88.9

94.4

12.24

1186

3782

(46235355) HIV 1 and 2 tests - Meaningful Use set

1436

5196

6.19

307.65

2.7

2.0

—

(3028707) Methadone [Presence] in Urine by Screen method

696

571

17.45

307.65

12.1

2.2

—

(4198724)

281

145

22.10

307.65

5.8

1.9

—

(1001926) Buprenorphine [Presence] in Urine by Screen method

799

1126

10.63

307.65

12.1

1.7

—

(3027008) Opiates [Presence] in Urine

838

1465

8.68

307.65

12.0

1.7

—

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

1362

4059

7.30

307.65

2.2

1.7

—

(3011288) Drugs identified in Urine by Screen method

842

951

13.81

307.65

16.1

2.2

—

(3016879) Cocaine [Presence] in Urine

842

1356

9.50

307.65

12.4

1.7

—

(3021879) Hepatitis B virus core Ab [Presence] in Serum

774

1969

5.55

298.88

1.9

1.5

—

(3042517) Benzodiazepines panel - Urine

147

78.75

274.87

5.7

1.5

—

(3007566) Smooth muscle Ab [Titer] in Serum

371

536

8.14

251.45

1.2

1.4

titre

93.3

88.4

0.10

(3032567) Hepatitis B virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

153

40.06

249.98

4.4

1.1

iu/ml

25385001.8

—

(42870588) Differential panel, method unspecified - Blood

1279

5428

4.29

245.05

7.1

6.4

—

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

1986

12142

8.28

224.72

11.1

7.2

u/l

81.1

74.4

11.48

1931

11555

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

437

862

6.09

218.44

1.6

1.4

—

(3009508) Creatinine [Moles/volume] in Urine

1094

4451

3.93

215.84

11.6

3.2

mmol/l

7.0

8.8

23.70

966

3877

(40758558) Short blood count panel - Blood

1021

3991

3.94

213.16

10.3

7.1

—

(3016650) Hepatitis A virus Ab [Presence] in Serum

283

368

8.69

208.50

1.3

1.1

—

(3023368) Bacteria identified in Blood by Culture

921

3496

3.83

198.03

7.6

4.2

—

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

193

160

13.14

195.97

7.3

1.5

—

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

264

355

8.33

188.69

1.2

1.1

—

(44816559) Phosphatidylethanol [Mass/volume] in Blood

307

490

7.13

188.37

2.0

1.3

—

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

615

1823

4.31

186.76

3.1

2.9

umol/l

8.8

7.5

0.64

499

1574

(3013650) Neutrophils [#/volume] in Blood by Automated count

1659

9585

4.08

179.99

16.8

9.4

e9/l

4.0

0.31

1498

8442

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

318

554

6.55

179.02

1.3

—

(3022096) Basophils/100 leukocytes in Blood

1446

7675

3.64

178.34

8.6

6.4

0.7

1.32

1380

7261

(3019069) Monocytes/100 leukocytes in Blood

1477

7979

3.65

176.33

8.8

6.5

8.5

8.4

0.26

1412

7583

(3006315) Basophils [#/volume] in Blood

1531

8484

3.71

174.98

9.0

6.2

e9/l

0.0

0.64

1360

7452

(3001604) Monocytes [#/volume] in Blood

1528

8459

3.71

174.86

9.1

6.2

e9/l

0.6

3.39

1358

7450

(3006504) Eosinophils/100 leukocytes in Blood

1468

7929

3.62

174.65

8.6

6.3

2.7

2.8

2.07

1399

7494

(3023183) Ammonium ion [Moles/volume] in Plasma

240

317

8.39

173.82

3.1

3.5

umol/l

37.5

34.4

0.89

214

278

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

538

1527

4.35

171.91

3.1

2.6

u/l

31.5

73.8

0.78

475

1342

(3013115) Eosinophils [#/volume] in Blood

1555

8774

3.71

171.07

10.4

6.6

e9/l

0.2

0.75

1386

7840

(3002030) Lymphocytes/100 leukocytes in Blood

1486

8298

3.49

162.90

8.7

6.2

30.7

29.1

5.63

1416

7860

(3021589) Normoblasts [#/volume] in Blood

1388

7440

3.39

162.88

12.6

8.7

e9/l

0.0

0.43

1173

6113

(3019198) Lymphocytes [#/volume] in Blood

1538

8772

3.57

162.82

9.1

6.2

e9/l

2.1

2.0

2.60

1380

7859

(3018010) Neutrophils/100 leukocytes in Blood

1468

8175

3.45

160.84

8.6

6.1

54.2

56.4

9.27

1402

7764

(3032080) INR in Blood by Coagulation assay

1100

5190

3.26

159.30

6.5

6.6

inr

1.1

2.09

343

1689

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

491

1382

4.30

157.59

4.7

2.9

—

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

177

189

10.11

151.07

1.2

1.1

—

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

1173

5933

3.12

147.29

7.9

6.0

mmol/l

1.2

11.71

1086

5470

(3000081) cloZAPine [Moles/volume] in Serum or Plasma

183

222

8.91

141.56

27.9

18.5

nmol/l

1382.8

1443.8

0.39

177

216

(3020191) Ethanol [Moles/volume] in Serum or Plasma

165

191

9.27

132.30

1.8

1.5

promille

1.3

1.5

0.49

128

151

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

1217

6641

2.89

126.99

8.7

6.6

mmol/l

1.2

12.03

1041

5646

(3013826) Glucose [Moles/volume] in Serum or Plasma

1468

8859

3.02

126.56

7.4

4.6

mmol/l

6.6

0.17

1383

8182

(3030467) Casts [#/volume] in Urine by Automated count

866

3951

2.98

126.33

3.2

2.9

e6/l

0.5

0.3

1.13

637

2924

(3014111) Lactate [Moles/volume] in Serum or Plasma

402

1178

3.96

119.86

8.7

7.9

mmol/l

1.4

0.35

384

1139

(3000991) Gas panel - Venous blood

383

1091

4.05

118.77

9.9

9.4

—

(3002032) Base excess in Venous blood by calculation

391

1135

3.98

118.04

4.2

3.9

mmol/l

1.6

2.0

1.22

307

927

(3021447) Carbon dioxide [Partial pressure] in Venous blood

393

1145

3.97

118.03

4.2

3.9

kpa

5.9

0.12

370

1117

(36304419) Bacteria [Presence] in Urine

850

3957

2.88

117.84

3.1

2.8

—

(3018095) Leukocytes [#/volume] in Urine

1018

5247

2.77

115.45

3.9

3.4

e6/l

48.5

61.7

0.46

686

3592

(3042936) Bacteria identified in Isolate by Culture

563

2102

3.26

115.23

2.7

2.1

—

(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma

175

259

7.26

113.91

3.1

3.6

u/ml

7196.4

100.6

0.73

170

236

(3002582) Erythrocytes [#/volume] in Urine

895

4351

2.80

113.31

3.3

2.9

e6/l

93.6

94.7

0.01

662

3305

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

277

638

4.83

113.04

3.7

3.8

mmol/l

23.9

24.4

1.29

247

582

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

1889

13652

3.91

110.52

7.1

3.0

u/l

66.9

45.0

15.87

1822

13114

(3007463) Buprenorphine [Presence] in Urine

110

231.56

107.67

10.4

3.8

—

(3018418) pH of Serum or Plasma

823

3928

2.76

106.71

4.1

7.4

1.16

145

782

(3003396) Base excess in Arterial blood by calculation

422

1398

3.50

103.87

9.6

9.2

mmol/l

0.8

0.9

0.20

341

1094

(3003458) Phosphate [Moles/volume] in Serum or Plasma

482

1740

3.27

103.26

7.6

6.9

mmol/l

1.0

0.55

462

1651

(3024354) Oxygen [Partial pressure] in Venous blood

324

920

3.96

100.06

3.7

3.1

kpa

5.3

4.8

3.17

302

897

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

922

4811

2.59

98.00

4.0

2.7

u/l

57.0

56.9

0.02

832

4526

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

550

2215

2.98

96.92

2.8

2.6

e6/l

3.1

2.0

1.74

268

1149

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

962

5148

2.56

96.62

2.0

1.7

pmol/l

95.1

96.9

0.60

502

2889

(3027801) Oxygen [Partial pressure] in Arterial blood

409

1406

3.35

94.29

9.9

9.1

kpa

11.5

13.0

7.36

390

1352

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

409

1406

3.35

94.29

9.9

9.1

kpa

5.3

5.1

4.50

390

1348

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

562

2347

2.88

92.13

2.6

2.5

e6/l

1.4

1.1

0.58

278

1278

(3027974) Hepatitis B virus e Ag [Presence] in Serum

143.39

90.79

2.2

1.0

—

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

815

4154

2.54

89.22

3.0

2.1

u/l

404.3

283.7

0.92

773

3954

(3013945) Hepatitis B virus e Ab [Presence] in Serum

189.82

87.93

2.2

1.0

—

(3031040) Bacteria [#/volume] in Urine by Automated count

1472

9869

2.52

86.83

4.8

3.6

e6/l

198.0

684.1

0.74

108

(3012095) Magnesium [Moles/volume] in Serum or Plasma

535

2279

2.79

83.57

3.8

mmol/l

0.8

6.01

492

2162

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

281

823

3.77

82.35

1.4

1.3

miu/ml

180.1

218.5

0.74

397

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

390

1409

3.15

82.01

2.1

1.7

—

(3015736) pH of Urine

1050

6196

2.34

80.79

6.0

2.8

—

5.6

—

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

393

1446

3.10

79.95

2.1

1.7

—

(3014576) Chloride [Moles/volume] in Serum or Plasma

423

1624

2.99

79.83

9.8

7.7

mmol/l

104.4

104.3

0.13

407

1594

(3002173) Hemoglobin [Mass/volume] in Arterial blood

343

1170

3.29

79.25

10.8

10.3

g/l

122.3

125.8

1.97

334

1130

(3016502) Oxygen saturation in Arterial blood

356

1243

3.23

79.13

10.6

9.8

95.2

96.4

3.49

348

1202

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

244

665

4.01

79.13

11.1

11.3

mmol/l

24.4

24.2

0.21

227

633

(3007853) Bacteria identified in Skin by Aerobe culture

467

1906

2.85

78.67

2.1

1.6

—

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

492

2075

2.77

77.77

2.1

1.8

—

(3026782) Osmolality of Urine

596

2766

2.59

77.77

2.9

2.6

mosm/kgh2o

524.1

564.2

3.54

517

2372

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

196

462

4.56

76.96

2.3

2.4

ug/l

606.8

325.1

0.76

186

434

(3022217) INR in Platelet poor plasma by Coagulation assay

372

1372

3.06

75.06

8.7

15.9

inr

1.1

1.2

1.07

227

(3020779) Urea [Moles/volume] in Serum or Plasma

335

1171

3.20

74.05

7.8

9.3

mmol/l

8.3

8.1

0.16

320

1127

(3005719) IgG [Mass/volume] in Serum or Plasma

363

1363

3.00

70.70

1.8

2.5

g/l

13.6

10.4

22.94

338

1245

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

226

642

3.81

68.84

2.0

1.5

—

(3019150) Specific gravity of Urine by Refractometry

661

3400

2.36

67.47

7.3

3.1

kg/l

1.0

0.70

446

(3028026) IgM [Mass/volume] in Serum or Plasma

305

1063

3.17

67.44

1.3

1.9

g/l

1.7

1.3

4.31

281

993

(3009466) Valproate [Moles/volume] in Serum or Plasma

156

341

4.85

67.04

5.7

6.4

umol/l

354.3

383.8

1.49

136

298

(3037522) Nuclear Ab [Titer] in Serum

532

2491

2.50

66.88

1.3

1.4

titre

235.3

478.1

5.78

110

458

(3000850) Epithelial cells [#/volume] in Urine

596

2956

2.40

65.88

2.7

2.5

e6/l

12.2

5.6

1.48

532

2610

(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification

115

8.03

64.90

13.5

8.8

u/ml

1317.6

16962.4

0.47

(3019550) Sodium [Moles/volume] in Serum or Plasma

2055

17246

4.45

64.54

24.6

11.5

mmol/l

138.8

139.6

46.53

2015

16822

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

9.91

63.89

1.6

3.6

umol/l

162.6

135.6

0.21

(3026008) Bacteria identified in Urine by Culture

639

3311

2.32

63.52

3.3

2.4

—

(3023103) Potassium [Moles/volume] in Serum or Plasma

2058

17330

4.46

63.38

24.5

11.6

mmol/l

4.0

3.9

0.21

2016

16867

(3018677) aPTT in Platelet poor plasma by Coagulation assay

464

2091

2.55

62.88

2.3

2.4

30.8

29.6

2.89

451

2026

(3015377) Calcium [Moles/volume] in Serum or Plasma

790

4494

2.19

62.31

3.1

3.2

mmol/l

2.3

0.97

688

4096

(3019309) Folate [Moles/volume] in Red Blood Cells

443

1968

2.57

61.76

1.8

1.6

nmol/l

1103.2

1168.4

0.72

330

1556

(3021960) Folate [Moles/volume] in Serum or Plasma

559

2776

2.36

60.99

1.6

1.4

nmol/l

18.2

19.9

2.44

508

2470

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

410

1807

2.56

57.79

2.6

2.5

22.7

25.1

1.92

359

1579

(1761868) Lipid panel - Serum or Plasma

426

8000

0.42

56.77

2.7

2.4

—

(3023511) Choriogonadotropin [Units/volume] in Urine

184

518

3.79

56.53

1.7

1.3

—

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

631

3389

2.21

56.49

2.3

2.1

mg/l

3.0

2.8

1.13

543

2955

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

218

689

3.40

56.21

11.0

12.3

—

(3040370) OLANZapine [Moles/volume] in Serum or Plasma

114

7.44

56.11

2.6

2.4

nmol/l

139.4

153.4

0.49

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

134

6.80

55.44

1.0

—

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

134

6.80

55.44

1.0

—

(3006922) Hepatitis E virus Ab [Presence] in Serum

144

6.55

55.27

1.1

—

(3037467) Urinalysis macro (dipstick) panel - Urine

1487

11021

2.10

55.01

4.6

3.6

—

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

522

2623

2.30

54.68

3.7

3.2

ng/l

260.2

551.0

1.58

333

1696

(3004789) Transferrin [Mass/volume] in Serum or Plasma

426

1968

2.45

53.98

2.5

2.4

g/l

2.4

0.40

386

1828

(3027945) Reticulocytes/100 erythrocytes in Blood

310

1236

2.76

53.15

2.8

1.9

1.8

1.24

262

1119

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

628

3444

2.16

52.77

2.6

2.0

—

(3044640) Blood type and Crossmatch panel - Blood

788

4722

2.05

52.16

3.1

2.2

—

(3013707) Erythrocyte sedimentation rate by Westergren method

1571

12012

2.11

51.68

3.9

3.7

mm/h

13.0

8.8

20.26

1445

11316

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

446

2145

2.36

51.41

2.8

mmol/l

2.4

4.31

375

1894

(3052851) Hemolysis interference index of Serum or Plasma

154

413

3.94

50.62

2.7

2.9

—

(3012984) Norclozapine [Mass/volume] in Serum or Plasma

17.39

49.77

8.0

10.0

—

(3002385) Erythrocyte distribution width [Ratio]

1864

15366

2.49

49.33

32.1

13.3

13.8

13.4

23.88

1849

15064

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

665

3809

2.07

49.27

2.7

2.1

—

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

229

814

3.03

48.34

1.7

1.5

—

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

181

5.44

47.66

5.5

6.5

mg/l

9.4

10.1

0.74

168

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

2045

17783

3.49

46.46

22.5

11.0

mg/l

24.2

21.4

3.77

1739

13693

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

326

1427

2.51

45.90

3.2

4.4

u/l

233.4

230.7

0.12

305

1355

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

115

268

4.47

45.52

1.9

1.6

—

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

618

3557

2.03

44.41

3.0

2.2

—

(3022948) Iron [Moles/volume] in Serum or Plasma

426

2128

2.25

44.29

2.5

2.4

umol/l

13.3

14.7

2.65

395

1982

(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood

131

5.98

42.38

3.3

2.9

36.4

43.8

1.55

(3024666) Lithium, Blood [Moles/volume] in Serum or Plasma

190

5.01

42.14

13.4

12.6

mmol/l

0.6

0.33

173

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

11.84

42.13

1.3

—

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

1854

15565

2.29

41.61

5.2

4.2

mu/l

1.8

1.9

0.75

1717

14663

(3019539) Treponema pallidum Ab [Titer] in Serum by Hemagglutination

119

306

4.06

41.38

3.0

2.1

titre

2485.7

1412.0

0.32

(21494755) Public health laboratory ask at order entry panel

3295

0.27

40.65

1.2

1.3

—

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

1931

16561

2.47

40.09

19.5

9.6

ml/min/173m2

97.1

92.2

16.83

1639

13638

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

155

499

3.27

38.53

4.0

3.1

mg/l

1.4

1.3

0.46

150

469

(3017509) Phencyclidine [Presence] in Urine

11.66

37.87

4.8

1.4

—

(3024928) Oxygen saturation in Venous blood

109

282

4.02

37.57

2.9

3.0

—

(3011397) Hemoglobin [Presence] in Urine by Test strip

577

3421

1.93

37.02

3.1

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

103

269

3.97

35.04

1.3

—

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

103

269

3.97

35.04

1.3

—

(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood

158

4.95

34.54

2.3

2.8

e6/l

877.4

750.5

—

(3004119) Hemoglobin [Mass/volume] in Venous blood

191

738

2.74

34.28

4.1

3.3

g/l

132.3

134.6

0.62

185

724

(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma

180

682

2.79

33.53

1.8

—

(3044889) 12 lead EKG panel

1415

11168

1.76

33.42

3.8

3.0

—

(40768441) Liver Pathology biopsy report

119

5.51

32.96

1.3

1.5

—

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

2098

19157

3.65

31.30

17.7

8.8

u/l

44.5

30.0

41.96

2078

18684

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

140

480

3.05

31.24

1.7

1.9

g/l

1.4

0.14

114

416

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

12.08

30.79

3.1

5.2

—

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

1574

12947

1.78

30.71

4.1

3.7

pmol/l

14.5

0.25

1442

12072

(3023520) Reticulocytes [#/volume] in Blood

201

854

2.49

29.66

2.5

2.9

e9/l

77.4

74.1

0.36

126

637

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

1002

7364

1.67

29.19

4.7

3.9

—

(3029634) Reagin Ab [Titer] in Serum by VDRL

117

376

3.23

29.12

3.4

2.5

titre

22.7

3.1

—

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

125

419

3.10

28.99

2.0

1.7

—

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

117

5.16

28.32

3.7

4.2

—

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

2626

0.31

28.16

1.5

1.6

—

(3036180) Methadone [Presence] in Urine

64.88

27.97

5.3

1.0

—

(3010421) pH of Blood

117

386

3.15

27.87

4.6

3.6

7.4

4.41

101

327

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

8.30

27.40

4.8

2.1

—

(3008152) Bicarbonate [Moles/volume] in Arterial blood

179

755

2.49

26.78

10.1

8.7

mmol/l

24.8

24.4

0.52

169

701

(3007164) IgA [Mass/volume] in Serum or Plasma

576

3717

1.75

26.73

1.4

g/l

2.6

2.3

2.86

361

2495

(3037121) Protein [Mass/volume] in Urine

134

497

2.81

25.92

4.1

3.6

g/l

0.3

0.14

240

(3012501) Base excess in Blood by calculation

103

333

3.20

25.38

4.7

3.7

mmol/l

2.1

0.06

217

(40768797) Stomach Pathology biopsy report

356

2011

1.92

25.38

1.2

—

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

109

365

3.09

25.32

2.6

2.9

—

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

868

6330

1.62

24.83

2.5

2.3

nmol/l

66.3

72.4

8.34

800

5924

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

136

520

2.72

24.82

2.9

2.8

g/l

3.5

3.6

0.59

131

494

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

150

4.23

23.41

1.1

1.3

titre

308.0

221.7

—

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

135

3027

0.41

23.21

1.4

—

(1616796) Gas panel - Central venous blood

321

3.08

22.37

4.3

3.2

—

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

212

1038

2.15

22.34

2.7

2.5

u/l

5535.8

5858.0

0.05

420

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

260

3.32

22.23

1.5

1.7

—

(3000093) Morphology [Interpretation] in Blood Narrative

110

4.72

22.23

1.1

—

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

562

3763

1.67

22.10

2.0

1.8

mg/l

1.4

0.9

1.01

431

2717

(3019060) Gas panel - Arterial blood

171

776

2.31

21.67

7.2

6.4

—

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

5.86

20.58

3.3

3.2

—

(3035947) Staphylolysin Ab [Units/volume] in Serum

5.27

20.35

1.2

1.1

iu/ml

5.4

4.5

—

(3027273) Bicarbonate [Moles/volume] in Venous blood

132

549

2.50

20.31

4.7

3.8

mmol/l

24.9

25.3

0.59

126

534

(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma

260

3.20

20.23

1.1

g/l

1.7

1.4

5.73

234

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

598

4150

1.61

20.07

1.6

mmol/l

1.6

1.5

1.51

542

3625

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

196

972

2.12

19.94

1.7

—

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

327

1946

1.80

19.42

2.3

2.1

—

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

273

1542

1.88

19.17

2.2

2.0

—

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

179

3.59

19.05

1.1

1.5

—

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

115

462

2.57

19.03

2.6

2.2

ug/l

1.5

2.0

0.32

104

426

(3028308) Erythrocytes [#/volume] in Pleural fluid

5.28

18.93

1.6

1.4

e6/l

32908.5

20139.4

0.36

(40761511) CBC panel - Blood by Automated count

2041

18957

2.24

18.71

20.7

9.9

—

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

273

3.04

18.65

1.5

1.7

g/l

0.0

0.00

262

(3035350) Ketones [Presence] in Urine by Test strip

1011

7988

1.50

18.38

3.5

3.0

estimate

0.0

0.80

225

1511

(40767503) Oxygen content in Capillary blood by calculation

287

2.97

18.27

3.2

2.2

16.4

17.4

1.21

146

(3023199) Leukocytes [#/volume] in Pleural fluid

4.89

18.27

1.6

1.3

e6/l

30532.3

1832.2

0.59

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

1796

0.33

18.11

1.3

1.4

—

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

300

2.91

18.05

1.8

1.7

g/l

0.0

0.00

289

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

125

536

2.41

18.01

5.5

2.6

180.6

172.7

0.37

118

517

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

271

2.99

17.65

1.5

1.7

g/l

0.0

0.00

262

(3009261) Glucose [Presence] in Urine by Test strip

1012

8051

1.48

17.46

3.5

3.0

estimate

0.0

0.80

228

1497

(3021601) Nitrite [Presence] in Urine by Test strip

1004

7986

1.48

17.27

4.9

4.2

estimate

0.0

0.50

229

1575

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

1815

16337

1.67

17.21

4.7

3.6

mmol/l

6.1

5.8

9.19

1665

15348

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

132

592

2.31

17.18

2.7

2.3

83.9

94.7

5.13

126

554

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

298

2.86

17.09

1.5

1.7

g/l

38.7

38.9

0.08

272

(3021387) Prolactin [Units/volume] in Serum or Plasma

197

1041

1.98

16.81

1.7

1.6

mu/l

383.0

276.4

2.80

161

950

(3000494) Fungus identified in Specimen by Culture

318

1958

1.73

16.63

1.5

—

(3001122) Ferritin [Mass/volume] in Serum or Plasma

960

7609

1.47

16.59

3.1

2.7

ug/l

118.3

113.9

0.27

877

7209

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

707

5273

1.50

16.57

4.1

2.9

ng/l

62.0

39.6

0.33

428

2873

(3033799) Differential panel - Peritoneal fluid

7.34

16.54

2.6

—

(3044007) Cell count panel - Peritoneal fluid

7.34

16.54

3.3

2.2

—

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

352

2.65

16.27

2.7

3.8

u/ml

0.3

1.05

181

(3045788) Cell count panel - Pleural fluid

5.06

16.21

1.6

1.4

—

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

332

2.69

15.98

1.8

g/l

0.6

0.7

0.08

312

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

403

2.53

15.96

3.5

6.6

iu/ml

1142.6

782.9

—

(3012441) Differential panel - Pleural fluid

4.57

15.65

1.5

1.4

—

(3009613) Erythrocytes [#/volume] in Peritoneal fluid

6.47

15.38

2.7

2.5

e6/l

697.3

2121.1

0.67

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

352

2.59

15.24

1.6

1.7

g/l

13.4

10.4

3.84

313

(3019832) Treponema pallidum Ab [Presence] in Serum

434

2957

1.58

15.17

1.9

1.8

—

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

111

489

2.34

15.07

6.9

7.3

2.5

1.7

4.66

103

459

(3023487) Leukocytes [#/volume] in Peritoneal fluid

5.80

14.93

2.6

2.7

e6/l

288.3

736.0

0.94

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

160

822

2.02

14.77

3.4

2.8

kpa

5.3

5.2

1.56

153

771

(3001019) Free T4 and TSH panel - Serum or Plasma

1389

0.32

14.73

1.5

1.6

—

(3025059) Transferrin.carbohydrate deficient [Mass/volume] in Serum or Plasma

9.07

14.67

2.1

1.1

mg/l

64.6

45.6

—

(3012516) Albumin [Mass/volume] in Urine

516

3683

1.53

14.58

3.2

3.4

mg/l

110.5

402.4

3.58

314

2484

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

153

783

2.03

14.27

3.4

2.8

mmol/l

1.9

1.5

0.59

118

571

(3006184) Hemoglobin [Mass/volume] in Capillary blood

282

2.72

14.20

2.5

2.2

g/l

129.9

136.3

1.19

210

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

390

2.45

14.10

1.9

1.7

g/l

7.5

7.1

0.75

310

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

390

2.45

14.10

1.9

1.7

—

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

390

2.45

14.10

1.9

1.7

g/l

3.6

3.9

1.93

290

(3020682) Albumin/Creatinine [Ratio] in Urine

532

3851

1.50

13.98

4.2

mg/mmol

24.9

10.4

2.32

328

2581

(3009343) pH of Capillary blood

156

811

1.99

13.93

3.4

2.8

7.4

1.24

112

(3036489) Thrombin time

135

667

2.09

13.85

3.0

2.2

22.4

21.1

2.22

123

581

(3007930) Methemoglobin/Hemoglobin.total in Blood

107

483

2.28

13.75

6.9

7.4

0.9

0.04

455

(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture

13.07

13.37

2.5

2.0

—

(3051651) Icteric interference index of Serum or Plasma

4.10

13.29

2.8

3.8

—

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

156

3.26

13.16

2.6

1.9

—

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

416

2.34

13.11

3.1

4.0

u/ml

54.9

950.1

1.27

357

(3021901) Oxygen saturation in Capillary blood

228

2.82

12.85

3.0

2.2

—

(3032035) Polymorphonuclear cells/100 leukocytes in Blood

376

2.40

12.83

4.6

4.2

53.1

56.1

1.62

376

(3015235) Bicarbonate [Moles/volume] in Capillary blood

328

2.49

12.76

3.4

2.4

mmol/l

24.8

24.6

0.15

294

(3019977) pH of Arterial blood

4.96

12.63

2.2

4.0

7.4

—

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

231

2.78

12.55

1.3

1.6

—

(40761536) Microorganisms panel - Urine sediment

233

1420

1.72

12.51

3.9

3.4

—

(3051611) Lipemic interference index of Serum or Plasma

117

3.55

12.40

2.9

3.5

—

(3011648) Oxygen content in Venous blood

118

3.52

12.25

1.8

2.2

11.4

11.8

0.19

118

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

372

2.37

12.22

1.8

1.7

g/l

3.1

3.0

0.11

297

(3047181) Lactate [Moles/volume] in Blood

423

2.28

12.19

7.5

8.2

mmol/l

1.3

1.2

0.30

370

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

400

2798

1.53

12.18

2.9

3.0

ng/l

1843.1

895.6

0.87

327

2237

(3020630) Protein [Mass/volume] in Serum or Plasma

162

897

1.87

12.00

2.1

2.3

g/l

68.3

67.6

0.47

149

847

(3003181) Sodium [Moles/volume] in Urine

176

3.00

11.98

1.6

1.4

mmol/l

42.9

67.9

3.23

145

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

4.56

11.89

1.4

1.5

ug/l

12.8

8.0

2.77

(3002331) Protein [Mass/volume] in Peritoneal fluid

6.97

11.86

1.7

1.5

g/l

115.5

23.3

0.42

(3009214) Lutropin [Units/volume] in Serum or Plasma

157

869

1.87

11.65

1.4

u/l

6.8

7.8

0.73

108

711

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

151

830

1.88

11.45

2.8

2.7

ng/l

165.5

136.1

0.34

135

711

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

182

1062

1.78

11.37

4.6

3.7

mmol/l

1.2

4.59

162

927

(3043409) Potassium [Moles/volume] in Arterial blood

360

2.33

11.28

7.1

4.7

mmol/l

3.8

3.9

0.30

343

(40768806) Pleura Pathology biopsy report

3.97

11.02

1.5

—

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

9.34

10.77

2.5

1.8

—

(3020891) Body temperature

101

494

2.10

10.69

8.9

4.9

—

(3039000) Anion gap in Blood

290

2.42

10.49

8.8

10.3

mmol/l

10.7

11.4

0.93

264

(3009542) Hematocrit [Volume Fraction] of Blood

1904

17799

1.56

10.44

29.0

11.3

40.2

41.5

13.63

1420

14833

(3018572) Chloride [Moles/volume] in Blood

291

2.42

10.41

8.8

10.3

mmol/l

104.1

105.4

1.05

265

(3000570) Elastase.pancreatic [Mass/mass] in Stool

426

2.16

10.37

1.4

ug/g

253.6

306.1

1.66

229

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

1688

15438

1.42

10.12

5.5

4.5

mmol/mol

38.2

38.5

0.59

1555

14709

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

5.47

9.92

1.4

3.4

—

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

5.47

9.92

1.4

3.4

—

(3013762) Body weight Measured

8.17

9.74

1.1

1.3

—

(3017446) Testosterone [Moles/volume] in Serum or Plasma

309

2143

1.52

9.66

2.7

2.3

nmol/l

13.7

13.9

0.15

253

1966

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

4.20

9.64

1.2

1.8

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

4.20

9.64

1.2

1.8

—

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

173

1044

1.71

9.62

3.0

4.7

ug/l

10.1

26.7

0.92

156

821

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

318

2.27

9.38

1.7

1.6

—

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

291

2.31

9.06

1.0

1.2

—

(3007461) Platelets [#/volume] in Blood

2120

20516

2.30

9.03

37.2

15.8

e9/l

236.0

253.8

21.82

2085

20117

(3013512) EKG study

477

3636

1.40

9.01

3.9

3.0

—

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

424

2.07

8.96

2.0

1.5

e6/l

43457.8

966.2

0.50

345

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

424

2.07

8.96

2.0

1.5

e6/l

35.1

13.6

1.01

332

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

117

3.11

8.95

1.5

1.6

—

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

372

2.14

8.86

1.2

1.8

—

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

474

2.00

8.85

1.2

—

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

435

2.04

8.73

1.3

1.5

—

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

408

2.08

8.72

1.3

1.5

u/ml

125.5

115.2

0.31

(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma

438

2.03

8.58

1.2

1.5

—

28.3

—

(3024731) MCV [Entitic volume]

2120

20550

2.23

8.40

37.0

15.8

90.5

90.0

6.60

2107

20354

(3035941) MCH [Entitic mass]

2120

20550

2.23

8.40

37.0

15.7

30.3

30.2

1.75

2107

20352

(3026361) Erythrocytes [#/volume] in Blood

2120

20554

2.22

8.33

37.1

15.8

e12/l

4.5

4.7

29.29

2077

20130

(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma

3.29

8.21

1.2

1.1

iu/ml

338.8

244.9

0.53

(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation

135

795

1.74

8.21

2.3

1.9

pmol/l

187.6

215.4

1.94

130

759

(3000963) Hemoglobin [Mass/volume] in Blood

2120

20564

2.20

8.15

37.4

15.9

g/l

136.1

140.7

32.89

2105

20362

(3010813) Leukocytes [#/volume] in Blood

2120

20564

2.20

8.15

37.3

15.9

e9/l

7.2

6.6

25.74

2078

20127

(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma

4.55

8.12

1.8

1.1

—

(44817194) Complement alternate pathway AH50 actual/normal in Serum by Immunoassay

4.55

8.12

1.8

1.1

98.4

99.8

0.07

(3002621) Streptococcal DNAse B [Units/volume] in Serum

9.13

8.09

1.0

1.2

—

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

6.53

8.07

1.1

—

(3044290) Cell count panel - Cerebral spinal fluid

401

2.03

8.00

2.0

1.5

—

(3029937) Albumin [Presence] in Urine by Test strip

525

4136

1.35

7.98

3.9

3.3

estimate

0.0

1.49

219

1529

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

3.54

7.97

3.6

2.0

—

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

237

1617

1.52

7.96

8.4

5.4

—

(3004588) Protein electrophoresis panel - Serum or Plasma

121

703

1.76

7.72

1.8

1.9

—

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

368

2.05

7.58

1.2

1.8

—

(3039443) Prostate specific Ag panel - Serum or Plasma

530

0.22

7.56

1.3

1.6

—

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

453

1.94

7.50

1.3

1.2

u/ml

313.1

250.6

1.10

295

(40760888) Immunoglobulin light chains.free panel - Serum

214

2.37

7.39

2.4

3.1

—

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

5.94

7.38

1.0

—

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

421

1.96

7.35

1.3

mmol/l

3.9

3.7

0.61

395

(3044242) Glucose [Moles/volume] in Arterial blood

4.03

7.35

2.5

3.2

—

(3019473) Protein [Mass/volume] in Cerebral spinal fluid

473

1.90

7.24

1.3

1.4

mg/l

572.0

484.3

0.50

449

(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma

3.69

7.19

1.5

2.3

umol/l

15.7

14.9

0.11

(3023410) Appearance of Cerebral spinal fluid

205

2.37

7.14

2.5

1.7

—

(3034860) Kappa light chains.free [Mass/volume] in Serum

282

2.16

7.13

2.2

2.9

mg/l

60.4

72.9

0.21

221

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

279

2.15

6.92

2.2

2.8

ratio

4.3

3.4

—

(3019897) Erythrocyte distribution width [Ratio] by Automated count

372

0.24

6.89

13.2

1.9

13.8

13.0

—

367

(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture

3.27

6.83

1.9

—

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

282

2.12

6.74

2.2

2.9

mg/l

47.3

31.0

1.15

219

(3017181) Myelocytes/100 leukocytes in Blood

196

1331

1.52

6.73

5.1

4.4

0.6

0.9

0.93

351

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

258

2.16

6.60

1.2

1.9

—

(3029075) Extractable nuclear Ab panel - Serum

3.82

6.53

1.1

1.0

—

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

147

2.54

6.45

1.1

1.2

—

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

149

965

1.58

6.33

2.3

2.2

ug/l

11.9

8.7

0.45

134

878

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

217

2.24

6.31

1.3

1.7

—

(4010399)

158

1041

1.56

6.24

1.3

1.4

—

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

379

2948

1.35

6.11

1.3

iu/ml

34.3

27.8

0.66

144

903

(3052592) Norovirus Ag [Presence] in Stool

5.81

6.11

2.9

1.4

—

(3002179) Metamyelocytes/100 leukocytes in Blood

180

1228

1.51

6.07

4.9

4.2

0.6

0.5

0.17

256

(3025159) Blasts/100 leukocytes in Blood

176

1201

1.51

5.93

5.4

4.5

0.1

0.08

267

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

137

885

1.58

5.90

5.0

4.4

ng/l

107.4

84.8

1.54

123

806

(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma

160

1071

1.53

5.90

2.2

1.8

nmol/l

50.3

36.0

8.87

148

1050

(3021440) Promyelocytes/100 leukocytes in Blood

183

1266

1.49

5.77

5.3

4.5

0.0

0.1

2.47

321

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

332

1.92

5.57

1.7

1.5

—

(3004809) Band form neutrophils/100 leukocytes in Blood

203

2.19

5.55

3.0

1.2

1.4

0.15

168

(44790048)

193

2.20

5.36

1.2

1.7

—

(44806118)

193

2.20

5.36

1.2

1.7

—

(44790049)

193

2.20

5.36

1.2

1.7

—

(44790047)

193

2.20

5.36

1.2

1.7

—

(3006653) Thiamine [Moles/volume] in Blood

2.88

5.35

1.0

1.4

nmol/l

151.1

142.1

0.34

(4281824)

108

2.61

5.22

1.4

1.2

—

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

986

0.53

5.21

1.8

1.9

—

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

508

4196

1.27

5.21

1.3

u/ml

1.6

1.8

0.10

1219

(3016018) Differential panel - Cerebral spinal fluid

203

2.14

5.15

2.6

1.5

—

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

320

4053

0.75

5.13

3.0

23.9

21.1

1.06

1342

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

3.02

5.10

1.1

1.0

—

(3027318) Ethylene glycol [Moles/volume] in Serum or Plasma

13.38

5.08

1.1

1.0

mmol/l

—

(3045462) Protein/Creatinine [Ratio] in Urine

5.28

5.04

3.3

4.7

g/mol

10.8

28.5

—

(3048929) Epstein Barr virus Ab [Presence] in Serum

122

805

1.55

4.84

1.3

1.2

—

(3022313) Gas panel - Capillary blood

576

1.64

4.81

3.4

2.9

—

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

346

2747

1.31

4.79

1.7

1.6

pmol/l

30216315.2

32934802.0

0.03

278

2423

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

265

1.95

4.75

1.3

1.6

—

(3034274) Bile acid [Moles/volume] in Serum --fasting

302

1.88

4.67

2.5

2.3

umol/l

5.1

6.1

0.53

220

(3025130) Human papilloma virus identified in Specimen

269

1.92

4.56

1.8

1.7

—

(3044941) Cell count panel - Synovial fluid

221

2.01

4.52

1.6

1.4

—

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

321

1.83

4.48

1.4

u/l

11.0

19.8

3.32

265

(42529406) Shigella sp [Presence] in Stool by Culture

517

1.65

4.47

1.3

1.2

—

(1002224) Polysomnography panel

1189

0.60

4.47

1.1

—

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

511

1.65

4.42

1.3

1.1

—

(3041806) Other cells [#/volume] in Blood by Manual count

112

0.00

4.37

0.0

1.6

—

(3014765) Yersinia sp identified in Stool by Organism specific culture

513

1.64

4.36

1.3

1.1

—

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

133

2.27

4.22

4.3

2.1

—

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

227

1.96

4.21

1.3

1.5

—

(40761535) Cells panel - Urine sediment

152

1082

1.44

4.19

3.5

3.2

—

(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

6.95

4.16

1.9

1.4

—

(3036481) Cortisol [Moles/volume] in Serum or Plasma

215

1627

1.36

4.14

2.2

2.1

nmol/l

351.4

364.8

0.55

193

1514

(3023419) Bacteria identified in Sputum by Culture

168

2.10

4.08

2.0

2.6

—

(3001964) Herpes simplex virus Ag [Presence] in Specimen

3.21

4.05

1.0

2.0

—

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

2.47

4.05

1.3

1.1

—

(3019225) pH of Specimen

164

1192

1.41

4.04

4.2

3.8

—

(4035726)

159

1151

1.41

4.01

1.5

1.4

—

(3040151) Glucose [Moles/volume] in Capillary blood

143

2.18

3.99

1.9

6.1

mmol/l

7.7

7.2

0.30

122

(3008295) Osmolality of Serum or Plasma

157

2.12

3.94

2.3

1.5

mosm/kgh2o

285.6

284.9

0.06

122

(3008757) Leukocyte morphology finding [Identifier] in Blood

133

2.20

3.80

2.8

3.0

—

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

2.49

3.80

1.1

—

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

194

1.98

3.78

1.3

1.5

—

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

3.35

3.76

1.2

1.1

—

(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)

165

1220

1.38

3.69

3.6

2.3

ml/min/173m2

68.2

76.5

1.36

442

(3024891) Influenza virus A+B Ag [Presence] in Specimen

584

1.55

3.69

1.2

1.1

—

(3023420) DNA double strand Ab [Units/volume] in Serum

203

1.94

3.68

1.4

1.5

iu/ml

18.6

20.9

—

(3000475) Leukocytes [#/volume] in Synovial fluid

320

1.74

3.66

1.8

1.7

e6/l

17582.1

12700.5

0.37

236

(3027923) C peptide [Moles/volume] in Serum or Plasma

2.43

3.64

1.5

1.8

nmol/l

1.6

1.2

0.42

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

1413

0.67

3.63

1.4

1.5

—

(3021788) Differential panel - Synovial fluid

240

1.85

3.62

1.6

—

(3042111) Morphology [Interpretation] in Bone marrow Narrative

184

1.97

3.58

1.4

1.8

—

(36660697) Celiac disease serology panel - Serum

195

1490

1.34

3.55

1.1

1.2

—

(3036035) von Willebrand factor (vWf) Ag actual/normal in Platelet poor plasma by Immunoassay

2.58

3.55

7.2

1.8

160.4

145.8

0.37

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

3.06

3.53

2.9

4.5

—

(40760892) CBC W Ordered Manual Differential panel - Blood

500

4294

1.21

3.46

7.3

4.5

—

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

180

1.96

3.44

1.2

1.9

—

(3017817) Protein [Mass] in Urine collected for unspecified duration

126

2.16

3.42

1.6

2.8

—

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

127

2.14

3.36

2.6

1.5

—

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

3.26

3.34

1.1

—

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

1637

17083

0.83

3.34

3.7

3.4

mmol/l

1.4

0.44

1492

16246

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

244

3034

0.78

3.33

2.2

2.3

ug/l

0.5

0.6

6.14

164

1528

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

2.63

3.30

1.4

1.1

—

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

115

2.19

3.29

1.3

1.6

—

(40768446) Kidney Pathology biopsy report

2.35

3.24

1.7

1.5

—

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

327

1.67

3.15

1.2

1.3

—

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

0.00

3.12

0.0

1.2

—

(3037756) Immunofixation for Serum or Plasma

187

1.89

3.11

1.3

1.7

—

(3003338) MCHC [Mass/volume]

1732

16626

1.20

3.06

33.8

13.3

g/l

333.7

334.7

4.37

1724

16514

(3018980) carBAMazepine [Moles/volume] in Serum or Plasma

2.69

3.06

2.6

2.5

umol/l

26.5

30.1

—

(3042631) Mycobacterium sp identified in Specimen

146

2.00

3.05

2.6

2.8

—

(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay

2.59

3.04

1.5

1.1

100.1

95.0

0.32

(3041678) Intrinsic coagulation system thromboelastography panel - Blood

5.85

3.02

1.7

1.6

—

(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis

4.30

2.99

6.6

4.5

mmol/l

5.7

7.6

—

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

127

2.06

2.97

2.0

1.8

mg/l

24.3

20.7

—

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

2.33

2.91

1.1

1.2

—

(3024471) HLA-A [Type]

2.38

2.89

1.0

—

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

2.38

2.89

1.2

1.3

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

122

2.06

2.87

1.2

1.8

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

122

2.06

2.87

1.2

1.8

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

122

2.06

2.87

1.2

1.8

—

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

200

1.81

2.86

1.3

1.7

—

(3045716) Anion gap in Serum or Plasma

2.41

2.80

1.6

2.3

mmol/l

8.0

8.9

—

(3043870) Heparin induced platelet Ab [Units/volume] in Serum

4.46

2.79

1.1

1.2

—

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

2.47

2.79

1.5

1.1

96.8

91.6

0.32

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

2.87

2.75

1.2

1.1

—

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

256

1.69

2.71

1.3

1.2

—

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

226

1.74

2.71

1.1

1.2

—

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

366

1.57

2.68

3.5

2.6

nmol/l

1.1

0.9

0.97

320

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

2.80

2.64

1.1

—

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

2.80

2.64

1.2

1.1

—

(3003740) Influenza virus B Ag [Presence] in Specimen

492

0.54

2.62

1.1

—

(3023323) Follitropin [Units/volume] in Serum or Plasma

140

1069

1.33

2.62

1.3

1.4

iu/l

19.0

22.0

0.66

902

(3022192) Triglyceride [Mass/volume] in Serum or Plasma

2.66

2.62

4.5

2.3

—

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

113

2.05

2.61

1.0

1.1

—

(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen

2.56

2.61

5.4

2.0

—

(3002523) Influenza virus A Ag [Presence] in Specimen

491

0.54

2.61

1.1

—

(3024932) HLA-DR beta [Type]

2.31

2.58

1.0

1.1

—

(3026493) Urate [Moles/volume] in Serum or Plasma

469

4107

1.18

2.57

2.6

2.4

umol/l

346.4

3865.3

8.28

409

3731

(3011412) CD3 cells [#/volume] in Blood

185

1.80

2.57

3.6

2.6

e9/l

1.4

1.3

0.20

107

(3023430) Cat dander IgE Ab [Units/volume] in Serum

395

0.50

2.52

1.1

u/ml

9.4

4.4

0.40

164

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

209

1.73

2.50

1.4

1.3

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

136

1.92

2.50

1.1

—

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

136

1.92

2.50

1.1

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

136

1.92

2.50

1.1

—

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

715

1.39

2.47

1.7

—

(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood

144

1.89

2.46

3.7

2.2

12.4

14.1

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

137

1.91

2.46

1.1

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

137

1.91

2.46

1.1

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

137

1.91

2.46

1.1

—

(3017354) Segmented neutrophils/100 leukocytes in Blood

123

1.96

2.45

2.7

53.0

57.0

0.29

(40761539) Cells [Type] in Urine sediment by Light microscopy

2.95

2.41

1.0

1.1

—

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

820

0.66

2.40

1.5

—

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

274

1.62

2.38

2.8

2.4

—

(3013139) Helicobacter pylori Ag [Presence] in Stool

141

1096

1.31

2.36

1.4

1.2

—

(40768443) Skin Pathology biopsy report

602

1.41

2.36

1.3

1.2

—

(4094501)

435

0.55

2.32

1.0

1.1

—

(3014133) Dog dander IgE Ab [Units/volume] in Serum

422

0.54

2.32

1.1

u/ml

4.2

3.5

0.08

167

(3010144) Erythrocytes [#/volume] in Synovial fluid

126

1.91

2.31

1.7

1.3

e6/l

36759.8

94333.7

0.50

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

2.13

2.28

1.1

1.2

—

(3010726) Horse dander IgE Ab [Units/volume] in Serum

483

0.57

2.28

1.1

u/ml

0.7

2.2

—

122

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

163

1.79

2.27

1.4

1.9

—

(3033705) Calcium.ionized [Moles/volume] in Venous blood

120

1.93

2.25

3.7

2.6

—

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

3.90

2.25

1.1

—

(37020271) Myelin oligodendrocyte glycoprotein Ab [Titer] in Serum by Cell binding immunofluorescent assay

3.90

2.25

1.0

1.2

—

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

1718

17710

0.86

2.21

4.0

3.7

mmol/l

1.3

1.4

21.20

1574

16871

(21494814) CD8 cells/100 lymphocytes in Specimen

2.20

2.21

5.3

2.1

—

(3003888) Timothy IgE Ab [Units/volume] in Serum

503

0.59

2.21

1.2

1.1

u/ml

4.0

6.8

0.69

257

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

143

1.83

2.19

1.3

2.0

—

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

234

1.64

2.17

1.2

u/l

69.4

36.0

0.44

197

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

2.03

2.16

1.2

—

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

917

0.70

2.15

1.4

1.7

mg/l

4.5

3.5

0.52

623

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

3.01

2.14

1.9

1.3

—

(3000012) Reticulocyte production index

2.37

2.12

1.2

1.7

—

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

607

0.64

2.12

1.4

1.5

—

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

358

0.53

2.12

1.2

1.0

u/ml

0.1

0.4

—

(3043238) Trisomy 21 risk [Likelihood] in Fetus

643

0.65

2.12

1.6

1.5

—

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

2.21

2.11

1.2

1.1

—

(3047352) Trisomy 18 risk [Likelihood] in Fetus

626

0.65

2.05

1.6

1.4

—

(3038864) risperiDONE [Moles/volume] in Serum or Plasma

4.01

2.04

1.2

nmol/l

12.8

35.0

—

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

552

0.63

2.03

1.2

1.1

u/ml

1.7

1.8

0.04

221

(40761995) Spermatozoa Progressive [#/volume] in Semen

177

0.39

2.03

2.7

3.1

—

(3014043) Spermatozoa Nonprogressive/100 spermatozoa in Semen

177

0.39

2.03

5.4

6.3

—

(3005033) Fetal Nuchal fold Thickness US

624

0.65

2.02

1.6

1.4

—

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

135

1070

1.28

1.99

2.1

3.4

pmol/l

4.4

4.6

1.22

108

974

(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

313

1.51

1.96

1.1

1.2

—

10.8

—

(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

4.55

1.94

1.0

1.1

—

(3035880) pH of Pleural fluid

2.45

1.93

1.2

—

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

294

0.51

1.92

1.2

1.4

pmol/l

41.2

167.0

—

102

(3003329) Lymphocytes/100 leukocytes in Synovial fluid

128

1.81

1.90

1.8

1.4

20.2

32.9

1.21

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

318

1.49

1.84

1.3

1.2

—

(3008401) Mugwort IgE Ab [Units/volume] in Serum

477

0.62

1.83

1.2

1.1

u/ml

0.2

1.2

2.40

193

(3041293) ARIPiprazole [Mass/volume] in Serum or Plasma

4.17

1.82

1.6

2.0

—

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

1731

17776

0.87

1.81

4.1

3.7

mmol/l

4.4

4.8

49.05

1590

16985

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

758

0.71

1.78

1.5

1.4

—

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

757

0.71

1.77

1.5

1.4

—

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

756

0.71

1.76

1.5

1.4

—

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

2.45

1.75

1.1

—

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

754

0.71

1.74

1.5

1.4

—

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

191

0.47

1.73

1.0

1.1

—

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

182

2163

0.83

1.69

1.8

—

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

341

1.45

1.69

1.3

u/ml

3.3

5.5

0.73

115

(3027456) Digoxin [Moles/volume] in Serum or Plasma

1.86

1.66

2.9

2.7

nmol/l

1.2

0.9

0.56

(42870308) Desmosome IgG Ab [Titer] in Serum by Immunofluorescence

2.10

1.65

1.0

1.3

—

71.3

—

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

318

1.46

1.65

1.1

1.3

—

4.6

—

(3017569) Oxygen content in Arterial blood

2.25

1.63

3.5

—

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

120

1.76

1.62

3.3

2.3

—

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

615

0.69

1.60

1.6

1.5

—

(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid

231

1.52

1.57

1.1

—

(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid

160

1.63

1.56

1.7

1.6

76.3

58.1

1.71

104

(21494890) Protein electrophoresis panel - 24 hour Urine

107

1.78

1.54

1.3

2.1

—

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

2.60

1.51

1.1

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

2.16

1.50

1.1

2.6

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

2.16

1.50

1.1

2.6

—

(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid

242

1.50

1.1

—

(3004716) Salmonella sp identified in Stool by Organism specific culture

132

1084

1.23

1.50

1.4

—

(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum

331

0.60

1.48

1.2

1.1

—

11.9

—

(3049717) Cytology report of Urine Cyto stain

385

1.39

1.48

2.2

2.3

—

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

148

1.63

1.44

1.4

1.1

—

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

611

0.71

1.42

1.8

1.7

—

(3042733) HLA Ab [Presence] in Serum

1.86

1.40

2.4

5.0

—

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

121

0.41

1.37

1.0

1.3

—

(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma

2.20

1.37

1.1

—

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

2.61

1.36

1.0

1.4

—

(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid

2.61

1.36

1.2

1.1

—

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

367

1.37

1.33

1.5

1.4

—

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

1.97

1.32

1.7

2.8

—

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

168

1.55

1.31

1.1

—

(3004446) Plasmodium sp identified in Blood by Light microscopy

2.50

1.30

2.2

3.0

—

(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid

2.50

1.30

1.2

1.1

—

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

335

1.38

1.29

1.4

1.3

u/ml

4.9

4.7

0.03

157

(3008116) Ketones [Moles/volume] in Urine by Test strip

2.36

1.29

1.6

1.3

—

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

2.05

1.26

1.4

1.3

—

(3002256) Pathology report gross observation

213

1860

1.16

1.26

1.2

—

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

516

0.71

1.25

1.4

1.5

—

(4268621)

236

1.45

1.25

2.2

2.4

—

(3010375) cycloSPORINE [Mass/volume] in Blood

1.74

1.25

22.8

28.1

ug/l

87.5

119.4

1.56

(4306422)

346

1.37

1.25

1.1

1.2

—

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

584

0.73

1.24

1.5

1.3

—

(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection

2.40

1.24

1.0

1.8

—

(3002619) Bacteria identified in Specimen by Culture

2.23

1.24

1.0

1.2

—

(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma

171

1.53

1.23

2.8

3.8

u/ml

22.5

23.7

0.06

166

(43534046) Estradiol (E2) [Moles/volume] in Serum or Plasma by High sensitivity method

2.31

1.18

1.0

nmol/l

0.3

0.2

—

(3034891) Synovial lining cells/100 cells in Synovial fluid

1.88

1.18

1.8

1.3

2.0

4.2

—

(3037692) Legionella sp identified in Specimen by Organism specific culture

2.00

1.16

1.1

1.9

—

(3026389) Candida sp identified in Specimen by Organism specific culture

190

1.48

1.16

1.5

1.3

—

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

325

1.36

1.16

1.2

1.1

—

(46235168) Fasting glucose [Moles/volume] in Blood

0.00

1.16

0.0

1.2

—

6.9

—

(3009871) Measles virus Ab [Titer] in Serum

1.73

1.15

1.5

1.6

—

(3045142) Bone marrow Pathology biopsy report

134

1.57

1.14

1.3

1.4

—

(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma

343

0.67

1.13

1.4

1.3

ug/l

2.3

3.0

1.00

317

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

1.69

1.13

1.4

1.3

—

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

1.97

1.11

1.1

2.6

—

(4034850)

530

1.27

1.11

13.4

8.0

—

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

226

1.42

1.10

1.1

—

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

2.19

1.08

1.0

1.5

—

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

479

5154

0.91

1.08

3.0

3.3

ug/l

2.1

1.7

0.17

401

4751

(3014326) Insulin-like growth factor-I [Moles/volume] in Serum or Plasma

202

1.44

1.07

1.6

1.9

nmol/l

17.6

20.5

0.74

192

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

1.69

1.07

1.3

1.6

—

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

137

1.54

1.05

2.1

2.8

e6/l

733.6

591.4

0.24

115

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

129

1.56

1.05

1.5

1.8

—

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

297

1.35

1.04

1.3

1.2

—

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

196

1.43

1.02

1.4

1.3

—

(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma

1.88

1.00

1.1

1.4

—

(3035320) C reactive protein [Mass/volume] in Body fluid

115

1.57

0.99

1.8

2.1

—

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

188

0.58

0.99

1.9

2.1

—

(40765089) Chromosome analysis panel - Blood by G-banded

132

0.53

0.99

1.0

—

(3043410) Blood group antigens tested for on Red Blood Cells

1.84

0.98

2.7

1.2

—

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

157

0.57

0.98

1.3

1.2

—

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

1.81

0.98

1.3

1.4

—

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

343

0.70

0.98

1.0

1.1

u/ml

6.6

2.4

—

187

(3017115) Methotrexate [Moles/volume] in Serum or Plasma

2.18

0.98

7.2

9.5

umol/l

0.2

0.3

—

(3022689) Creatine [Moles/volume] in Urine

1.95

0.97

1.7

1.4

—

(3050129) First trimester maternal screen panel - Serum or Plasma

922

0.82

0.96

1.4

—

(3024980) IgG subclass 4 [Mass/volume] in Serum

328

1.32

0.96

1.3

1.8

g/l

0.8

0.10

253

(3011985) Renin [Units/volume] in Plasma

200

1.41

0.93

1.5

mu/l

107.7

53.5

0.35

178

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

330

1.31

0.92

1.2

1.4

—

(3020717) Zinc [Moles/volume] in Serum or Plasma

1.60

0.90

2.2

1.6

umol/l

10.5

31.5

6.68

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

1.75

0.90

1.3

1.4

—

(3005322) IgE [Units/volume] in Serum or Plasma

110

1279

0.85

0.89

1.2

1.3

u/ml

162.2

236.7

0.75

102

1193

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

1.69

0.88

1.2

2.2

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

1.69

0.88

1.2

2.2

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

1.69

0.88

1.2

2.2

—

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

156

0.58

0.88

1.3

1.2

—

(3035637) Corticotropin [Mass/volume] in Plasma

195

1.39

0.86

2.3

1.6

—

(3014051) Protein [Presence] in Urine by Test strip

291

1.31

0.85

1.6

1.8

—

(40757373) Influenza virus identified in Isolate

1.94

0.84

1.0

2.2

—

(3039602) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Capillary blood

1.94

0.84

1.7

1.5

mmol/l

1.2

—

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

1.57

0.84

1.0

1.2

—

(3000034) Microalbumin [Mass/volume] in Urine

129

1.48

0.83

3.8

2.8

mg/l

149.2

53.6

0.60

(3004451) EKG impression Narrative

1.70

0.82

1.5

1.3

—

(3001893) Eosinophils/100 leukocytes in Pleural fluid

1.88

0.81

1.8

1.3

9.8

1.4

—

(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood

130

1.47

0.80

2.2

2.9

e9/l

0.1

0.2

1.22

112

(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay

1.82

0.79

1.0

1.1

—

(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum

0.00

0.79

0.0

1.0

—

(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection

106

1.51

0.79

1.6

2.0

—

(3008898) HLA-B27 [Presence]

857

0.83

0.79

1.1

—

(3000330) Specific gravity of Urine by Test strip

584

1.21

0.78

3.8

2.7

—

(3000492) Spirometry study

228

2075

1.11

0.78

1.4

—

(3034426) Prothrombin time (PT)

1.59

0.78

1.0

1.3

—

(3034988) Calcium [Moles/volume] in Capillary blood

1.77

0.76

1.8

mmol/l

1.2

—

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

350

1.26

0.76

1.1

—

(4146454)

124

1.46

0.75

3.1

2.7

—

(3003694) ABO and Rh group [Type] in Blood

566

5371

1.07

0.75

1.6

—

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

1.60

0.75

1.8

—

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

414

1.24

0.74

2.3

1.8

—

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

184

1.36

0.74

1.0

1.5

—

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

1.64

0.73

1.1

—

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

100

1.50

0.72

1.2

1.1

miu/ml

1521.5

1481.2

0.04

100

(3047007) Chlamydophila sp Ab [Presence] in Serum

322

0.74

0.72

1.2

—

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

333

0.75

0.72

1.3

1.2

—

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

1.93

0.70

1.6

1.2

—

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

186

1.35

0.70

1.0

1.5

—

(3014271) Vancomycin [Susceptibility]

1.71

0.70

3.1

2.2

—

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

257

1.29

0.68

1.2

1.3

—

(3005011) Chlamydia sp Ab [Titer] in Serum

1.85

0.68

1.4

1.3

—

(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

1.67

0.68

7.9

4.9

—

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

598

1.18

0.64

2.4

2.2

—

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

524

1.19

0.64

2.0

1.9

—

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

179

1630

1.11

0.63

3.8

3.6

30.8

29.7

0.69

128

1221

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

130

0.61

0.63

1.3

1.9

—

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

252

1.27

0.62

4.8

3.4

—

(3036071) Salmonella sp Ab [Titer] in Serum

1.52

0.62

1.1

—

(4027681)

164

1.34

0.62

1.3

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

1.55

0.62

1.2

2.2

—

(3028433) Virus identified in Specimen by Culture

1.63

0.62

1.3

1.2

—

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

471

1.19

0.61

2.0

1.7

—

(3025468) Yersinia sp identified in Specimen by Organism specific culture

182

1.32

0.61

1.0

1.5

—

(3035457) Cefaclor IgE Ab [Units/volume] in Serum

0.00

0.60

0.0

1.1

—

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

1.50

0.59

1.3

1.7

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

184

1.31

0.57

1.0

1.5

—

(3005988) Vibrio sp identified in Specimen by Organism specific culture

184

1.31

0.57

1.0

1.5

—

(40768800) Prostate Pathology biopsy report

219

0.73

0.57

1.3

1.2

—

(1761482) Bacteria [#/volume] in Urine by Culture

274

1.24

0.56

5.1

3.4

—

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

1.67

0.56

1.2

1.1

—

(3024522) Salmonella sp identified in Specimen by Organism specific culture

185

1.30

0.56

1.0

1.5

—

(3028679) Herpes simplex virus Ab [Presence] in Serum

124

1.37

0.55

1.5

1.2

—

(3014148) Varicella zoster virus Ab [Titer] in Serum

312

1.22

0.54

1.3

1.2

—

(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose

294

0.78

0.53

1.2

1.3

mmol/l

7.0

6.9

0.07

214

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

1.43

0.52

3.1

3.5

—

(3005791) Eosinophil cationic protein (ECP) [Mass/volume] in Serum

0.62

0.52

1.2

2.5

ug/l

18.4

339.8

—

(3044927) Protein electrophoresis panel - Urine

0.60

0.52

1.0

1.1

—

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

682

0.86

0.51

1.4

1.5

—

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

668

1.14

0.51

1.6

iu/ml

0.5

0.2

0.37

119

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

189

1.27

0.49

1.4

1.3

nmol/l

—

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

539

0.85

0.48

1.1

—

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

422

1.16

0.45

1.2

u/ml

4.0

10.3

—

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

516

1.15

0.44

1.3

1.9

—

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

121

1.32

0.44

1.3

1.2

—

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

148

1.29

0.43

1.1

—

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

462

1.15

0.42

1.2

—

29.1

—

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

0.65

0.42

3.8

6.9

—

(1617658) Protocol used for examination of sentinel lymph nodes

0.64

0.42

1.0

1.1

—

(3036312) Salmon IgE Ab [Units/volume] in Serum

0.00

0.41

0.0

1.0

—

0.3

—

(3007700) Barley IgE Ab [Units/volume] in Serum

0.00

0.41

0.0

1.1

—

1.3

—

(3041096) Erythrocytes [Presence] in Urine by Automated

463

4810

0.95

0.41

3.5

2.6

—

(3022475) Manganese [Moles/volume] in Blood

0.00

0.41

0.0

1.3

—

(3007542) Rye IgE Ab [Units/volume] in Serum

0.00

0.40

0.0

1.1

—

1.7

—

(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma

0.00

0.40

0.0

2.3

—

111.1

—

(3020356) Listeria sp identified in Specimen by Organism specific culture

0.00

0.40

0.0

1.1

—

(3030558) Cytomegalovirus DNA [Units/volume] (viral load) in Specimen by NAA with probe detection

1.31

0.39

1.1

2.0

—

55757.9

—

(3004905) Lipase [Enzymatic activity/volume] in Serum or Plasma

1.43

0.39

2.2

3.0

—

208.3

—

(43055514) Macroprolactin [Presence] in Serum or Plasma

1.41

0.39

1.0

1.4

—

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

428

1.15

0.39

1.9

2.1

iu/l

2.8

4.6

2.36

165

(3018001) Oat IgE Ab [Units/volume] in Serum

0.00

0.39

0.0

1.1

—

0.4

—

(3017732) Neutrophils [#/volume] in Blood

129

1193

1.09

0.38

3.1

2.5

e9/l

4.2

0.03

1011

(3045683) HLA typing for celiac disease panel - Blood or Tissue

148

0.74

0.38

1.0

—

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

1.38

0.38

1.4

1.7

—

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

312

0.83

0.38

1.0

1.1

—

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

188

1.23

0.37

1.0

1.1

—

(3035933) Granulocytes/100 leukocytes in Blood

1.31

0.37

9.7

1.7

—

(40758292) HTLV I+II Ab panel - Serum

1.35

0.37

1.6

1.4

—

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

122

1317

0.92

0.37

1.2

iu/ml

136.7

144.1

0.05

528

(3010838) Calcium [Moles/time] in 24 hour Urine

0.65

0.35

1.8

1.6

—

8.5

—

(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection

1.43

0.35

1.2

—

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

0.63

0.35

1.4

1.1

—

(3013166) Neutrophils/100 leukocytes in Synovial fluid

1.31

0.33

2.0

1.2

43.2

45.3

—

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

1496

14793

1.04

0.32

3.7

3.4

—

(3022621) pH of Urine by Test strip

908

1.08

0.30

2.4

2.1

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

281

2706

1.04

0.27

1.5

—

(3029396) Erythrocyte agglutination [Presence] in Blood

1.21

0.26

4.3

3.3

—

(40768804) Tissue Pathology biopsy report

637

6234

1.03

0.26

2.0

1.9

—

(3048402) Erythrocytes [#/area] in Urine sediment by Automated count

1.20

0.25

1.3

1.6

u/field

1.4

4.4

—

(3007368) IgG [Mass/volume] in Cerebral spinal fluid

198

1.16

0.24

1.2

mg/l

54.5

41.8

0.36

157

(3024263) Appearance of Synovial fluid

1.17

0.24

1.2

1.9

—

(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal

190

0.84

0.23

1.6

1.5

—

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

469

4577

1.03

0.23

1.6

—

(3024474) Albumin [Mass/volume] in Cerebral spinal fluid

190

1.16

0.23

1.1

mg/l

207.6

258.2

1.53

162

(21494434) Karyotype in Bone marrow

1.24

0.23

1.2

1.3

—

(3018851) Theophylline [Moles/volume] in Serum or Plasma

0.00

0.21

0.0

2.4

—

39.2

—

(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection

0.00

0.21

0.0

5.3

—

(46234834) Bacteria identified in Bone by Anaerobe+Aerobe culture

0.00

0.21

0.0

1.2

—

(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine

0.00

0.21

0.0

2.2

—

(3040668) CNBP gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

0.00

0.21

0.0

1.0

—

(3041672) Baker's yeast Ab [Presence] in Serum

0.00

0.21

0.0

1.0

—

(3014114) Aureobasidium pullulans IgG Ab [Mass/volume] in Serum

0.00

0.21

0.0

1.0

—

(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)

0.00

0.21

0.0

1.1

—

(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid

0.00

0.21

0.0

1.0

—

(3008092) Baker's yeast IgG Ab [Units/volume] in Serum

0.00

0.21

0.0

1.0

—

30.8

—

(3027401) Testosterone Free/Testosterone.total in Serum or Plasma

0.00

0.21

0.0

1.5

—

1.6

—

(40761545) Erythrocytes.dysmorphic [Presence] in Urine sediment by Light microscopy

0.00

0.20

0.0

1.1

—

(3000285) Sodium [Moles/volume] in Blood

0.00

0.20

0.0

1.1

—

(40768795) Lymph node Pathology biopsy report

136

1.18

0.20

2.1

1.3

—

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

111

0.81

0.20

1.8

1.1

—

(3036048) Francisella tularensis Ab [Titer] in Serum

1.23

0.20

1.2

1.0

—

(4062490)

197

0.86

0.19

1.1

1.3

—

(3051387) C reactive protein [Mass/volume] in Capillary blood

312

0.90

0.19

4.3

2.9

mg/l

10.5

24.3

4.43

187

(3015024) Glucose [Moles/volume] in Serum or Plasma --1 hour post dose glucose

206

0.87

0.18

1.2

1.6

mmol/l

7.2

7.4

—

125

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

1.19

0.18

1.0

1.1

—

(3003327) Ova and parasites identified in Stool by Light microscopy

682

0.94

0.18

1.9

1.8

—

(3032773) Endomysium IgG Ab [Titer] in Serum

174

0.86

0.17

1.2

1.1

—

(3028192) IgG subclass 2 [Mass/volume] in Serum

195

0.87

0.17

1.1

1.3

g/l

3.1

3.0

0.03

135

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

1.22

0.17

1.1

—

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

0.73

0.17

1.0

1.1

—

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

186

1.13

0.17

1.1

—

(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal

186

1.13

0.17

1.1

1.4

mmol/l

13.4

12.7

0.17

(3024139) IgG subclass 3 [Mass/volume] in Serum

194

0.88

0.16

1.1

1.3

g/l

0.5

0.4

0.74

133

(3027135) IgG subclass 1 [Mass/volume] in Serum

194

0.88

0.16

1.1

1.3

g/l

7.4

6.6

0.24

135

(3048689) Calprotectin [Mass/mass] in Stool

255

2487

1.03

0.15

2.3

2.7

ug/g

127.9

129.9

0.03

203

2045

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

647

6391

1.02

0.13

3.9

3.0

—

(3016244) Insulin [Units/volume] in Serum or Plasma

137

0.88

0.12

4.3

4.1

mu/l

31.2

36.1

0.21

132

(40768793) Breast Pathology biopsy report

271

0.92

0.11

1.3

—

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

222

1.08

0.10

1.0

1.1

—

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

565

0.95

0.10

1.1

u/ml

1.8

3.9

—

(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay

1.04

0.09

3.2

2.8

—

(3017704) Immunofixation for Urine

1.09

0.09

1.0

1.6

—

(3038026) Centromere Ab [Units/volume] in Serum

107

1.12

0.08

1.2

—

128.0

—

(3045424) Erythrocytes [Presence] in Urine

277

0.94

0.08

1.6

1.4

—

(3023659) Complement C1 esterase inhibitor.functional/Complement C1 esterase inhibitor.total in Serum or Plasma

0.80

0.07

1.0

1.1

134.8

108.4

—

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

0.86

0.07

1.4

1.2

—

(3015171) Extractable nuclear Ab [Units/volume] in Serum

691

0.97

0.07

1.2

u/ml

0.3

1.1

—

(3045414) Leukocytes [Presence] in Urine

650

1.03

0.06

1.6

—

(3025941) Bacteria identified in Stool by Culture

113

1107

1.02

0.06

1.4

1.2

—

(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum

109

1.10

0.06

1.2

—

67.8

—

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

399

1.03

0.03

1.4

1.5

nmol/l

0.2

0.4

4.95

329

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

800

1.01

0.02

1.9

2.1

u/l

50.9

40.3

2.13

740

(3004616) Nuclear Ab [Presence] in Serum

177

0.96

0.01

1.2

—

(3038177) Helicobacter pylori Ab [Presence] in Serum

373

1.02

0.01

1.6

1.1

—

(3022145) Colonoscopy Study observation

180

1808

1.00

0.01

1.3

1.4

—

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

275

2756

1.00

0.00

1.3

u/ml

9.8

9.4

0.04

1208

(44813793)

141

0.99

0.00

1.1

1.0

—

(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma

311

1.00

0.00

1.4

pmol/l

80.9

110.8

0.37

304

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

106

1059

1.00

0.00

1.0

1.1

—

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

333

0.99

0.00

2.4

2.6

ug/min

341.0

138.7

0.59

215

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

123

0.98

0.00

1.2

1.3

—

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

1791

17907

1.00

0.00

4.5

3.9

mmol/l

2.7

2.9

32.38

1637

16999

(4211845)

0.95

0.00

1.5

2.4

—

(4024509)

0.98

0.00

1.6

1.3

—

(40758358) Immune stain study

0.00

0.0

1.0

—

(3050099) BK virus DNA [#/volume] (viral load) in Specimen by NAA with probe detection

0.00

0.0

4.7

—

(3007302) Hemoglobin [Mass/volume] in Mixed venous blood

0.00

0.0

4.8

—

(40766799) MGMT gene methylation score in Tissue by Molecular genetics method

0.00

0.0

1.0

—

(723473) SARS-CoV-2 (COVID-19) IgA Ab [Presence] in Serum or Plasma by Immunoassay

0.00

0.0

1.3

—

(3012989) Citrate [Moles/time] in 24 hour Urine

0.00

0.0

1.5

—

2.6

—

(3025018) Bordetella pertussis Ab [Titer] in Serum

0.93

0.00

1.0

1.2

—

(3016135) IgD [Mass/volume] in Serum

0.00

0.0

1.3

—

160.5

—

(40760410) HLA-B [Type] by High resolution

0.00

0.0

1.0

—

(46236302) HLA-C [Type] by High resolution typing

0.00

0.0

1.0

—

(3018688) Ampicillin IgE Ab [Units/volume] in Serum

0.00

0.0

1.0

—

(3013862) HLA-DP [Type]

0.00

0.0

1.0

—

(3027505) Alpha-1-Fetoprotein [Units/volume] in Amniotic fluid

0.00

0.0

1.0

—

(3014591) Smooth Alder IgE Ab [Units/volume] in Serum

0.00

0.0

1.0

—

(3007625) Streptococcus pneumoniae Ag [Presence] in Specimen

0.00

0.0

2.1

—

(3032333) Phosphate [Mass or Moles] in 24 hour Urine

0.00

0.0

1.0

—

(3007919) Fasciola sp Ab [Titer] in Serum

0.00

0.0

1.0

—

(40765091) Chromosome analysis panel - Chorionic villus sample by G-banded

0.00

0.0

1.0

—

(3003157) Bacteria [#/volume] in Mother's milk

0.00

0.0

8.0

—

(3040794) Aluminum [Moles/volume] in Urine

0.00

0.0

1.1

—

(3010657) Triiodothyronine (T3) Free [Mass/volume] in Serum or Plasma by Dialysis

0.00

0.0

1.8

—

(3025886) Oxalate [Mass/time] in 24 hour Urine

0.00

0.0

1.0

—

(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk

1.01

0.00

1.0

—

(3002719) Hemoglobin [Mass/volume] in Urine

0.00

0.0

1.2

—

(3042391) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method

0.00

0.0

4.1

—

(3043649) Fibrin monomer [Presence] in Platelet poor plasma by Hemagglutination

0.00

0.0

1.0

—

(21494227) Amikacin free [Mass/volume] in Serum or Plasma

0.00

0.0

5.4

—

2.0

—

(3001729) Color of Synovial fluid

0.00

0.0

1.2

—

(40760409) HLA-A [Type] by High resolution

0.00

0.0

1.0

—

(40763480) Human metapneumovirus Ag [Presence] in Specimen

0.00

0.0

2.1

—

(36303722) Certolizumab [Mass/volume] in Serum or Plasma by Immunoassay

0.00

0.0

1.0

—

29.7

—

(3029612) Listeria sp Ab [Titer] in Serum

0.00

0.0

1.2

—

(3016284) Epstein Barr virus nuclear Ab [Units/volume] in Serum

0.00

0.0

1.0

—

(40763590) HLA-DQ beta [Type]

0.00

0.0

1.0

—

Mortality – FinRegistry

↥

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

Relationships between endpoints

↥

Index endpoint: HEPATITIS_CHRONIC_VIRAL – Chronic viral hepatitis

GWS hits: -

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

≡ Risteys

FG R12 + FR

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Chronic viral hepatitis

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

All original rules

Similar endpoints

Case counts by codes

Upset plot

Case counts by code for Chronic viral hepatitis (HEPATITIS_CHRONIC_VIRAL)

Summary Statistics

-FinRegistry-

-FinnGen-

Key figures

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

Matched cohort

LabWAS

Mortality – FinRegistry

Relationships between endpoints